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ABSTRACT 
 
CHRONIC CARE MANAGEMENT TO IMPROVE ADHERENCE: A 
COMPARISONOF APPROACHES IN THE CARE OF DIABETES  
 
By Mary Ellen Gervais 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2010 
Director: Dolores G. Clement, Dr.P.H., Professor, Department of Health Administration 
 
Managing chronic conditions is seen as the public health challenge of the 21st 
century.  The number of Americans with chronic conditions is expected to rise to 157 
million by 2020.  Diabetes prevalence and costs contribute to the growing problem.  
Diabetes was the seventh leading cause of death in 2006.  Nationally, the cost of diabetes 
is expected to be $138 billion in 2020. Diabetes leads to multiple and significant 
complications. 
The desired outcomes of management of chronic conditions are improvement in 
clinical status, avoidance of complications, prevention of co-morbid conditions and 
avoidance of the costs associated with complications.   In the 1990s, disease management 
programs were implemented in an attempt to effectively manage chronic conditions.
  
 
The primary approach in these programs focuses on individual-level interventions.  
Despite these efforts, poor outcomes exist. As a result, other approaches to diabetes 
management are being explored.  
This study examines a system-level approach to diabetes management versus an 
individual level one.  The system level approach is based on full implementation of the 
Chronic Care Model, framed in Social Ecology Theory.  This retrospective, non-
experimental study explores changes in adherence to select diabetes screening guidelines 
based on the approach to adopted by two health plans. Analyses were conducted on 
adherence to LDL, A1c, retinopathy and nephropathy screening 2 ½ years after program 
implementation.  In addition, logistic regression analyses were conducted on the 
predictive impact of approach to chronic care management in relation to changes in 
adherence.  Other variables known to impact health behaviors were factored into the 
analysis. 
     There were two main findings of the study.  The first is that for each of the 
screenings, there was a statistically significant difference between participants in the two 
plans. Comparisons of changes in adherence by approach from before implementation to 
after implementation resulted in a small number of subjects in some cells which can lead 
to accepting the null hypothesis when it is false. The second is that approach to 
management was associated with changes in adherence to three of the four screenings. 
The logistic models, however, account for less than 23% of the variance in adherence, a 
moderate effect size.  
 
 
1 
CHAPTER 1: INTRODUCTION 
 
“The function of protecting and developing health must rank even above that of restoring 
it when it is impaired.” Attributed to Hippocrates by Dr. James S. Marks (Marks, 2003).   
Introduction to the Problem 
Chronic Illness 
Managing chronic illnesses presents a challenge for the individuals who contend 
with these illnesses, employers who often carry the financial burden of these illnesses, 
and for federal and state governments that carry the burden for those individuals insured 
under Medicare and Medicaid.  Chronic illnesses or conditions are those health problems 
that persist over a long period of time and are not easily or often not at all resolvable 
(National Institute of Health, 2007). The prevalence of chronic illnesses has increased 
and is expected to continue to increase.  According to a report published by the National 
Institute for Health Care Management “caring for individuals with chronic conditions 
will be the public health challenge of the 21st century” (Anderson, 2002, p. 1).  
According to Anderson (2002) the number of individuals with chronic conditions is 
expected to rise from 105 million in 2000 to 134 million by 2020.  More recent data have 
lead to a re-adjustment of those predictions.  In 2004, more than 133 million Americans 
were diagnosed with a chronic illness leading to a new 2020 prediction of more than 157 
million affected Americans (Anderson, 2004).   
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Statistics from the Centers for Disease Control (CDC) on the impact of chronic 
conditions are staggering:   
• For Americans, chronic illnesses account for seven out of ten deaths 
• Chronic conditions cause limitations in activities of daily living for one of 
every ten Americans 
• The medical care costs associated with chronic illnesses accounted for $1.05 
trillion of the nation’s $1.4 trillion medical costs which represents 75% of all 
medical costs. (Centers for Disease Control and Prevention, 2009; Marks, 
2003) 
The personal burden of chronic illnesses includes multiple stressors. Individuals 
with chronic conditions contend with symptoms associated with the condition, as well as 
associated complications.  They often suffer from pain and fear that the condition may 
limit their ability to live a functional life.  Depression is a significant co-morbidity of 
chronic illness.  According to a report published by the Cleveland Clinic (2003) 
approximately a third of individuals with chronic illnesses also suffer from depressive 
symptoms. The personal financial burden is also high.  Individuals with chronic 
conditions experience higher out-of-pocket costs, and a higher proportion report 
difficulty paying their medical bills than those without chronic conditions (Ha, 2004).  
The employer’s burden is realized in both the rising costs of health insurance 
premiums and the loss of employee productivity.  Sixty-eight percent of insured 
individuals with chronic conditions are covered under private health insurance (Ha, 2004).  
The National Coalition on Health Care [ca. 2008] reported that in 2007 the cost of 
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insurance premiums for employers rose to 4 times the rate of inflation, a 119% rise.  
Druss, Marcus, Olfson, and Pincus (2002) reported on the most expensive medical 
conditions in relation to lost work days on a national level. Days lost ranged from 1.1 
million for congestive heart failure to 78.2 million for mood disorders such as depression.  
The loss of productivity is increasingly being seen as a significant factor in calculating 
the total cost of chronic conditions. In a report published by the American College of 
Occupational and Environmental Medicine (Collins et al., 2005) absenteeism and work 
impairment were significantly impacted by the presence of a chronic condition:  
absenteeism ranged from .9 to 5.9 hours in a four-week period and productivity decreased 
by 17.8% to 36.4%.  
The federal and state government’s burden is seen in the rising costs of public 
health insurance programs such as Medicare and Medicaid.  Medicare costs are expected 
to continue to rise.  Medicare expenditures are expected to increase from 2.7% of gross 
domestic product in 2005 to 11.3% in 2080 (Center for Medicare and Medicaid Services, 
2007).  A Kaiser Foundation report on Medicaid and the uninsured (Smith et al., 2004) 
found that Medicaid enrollment increased by nearly one-third since 2001 and Medicaid 
spending increased overall by 9.5% in 2004.  In 2006, Medicaid spending rose by only 
2.8%, the smallest amount in more than 10 years (Lee, 2006).  This slower growth is 
attributed to the implementation of Medicare Part D, which covers a higher proportion of 
pharmacy costs (National Governors Association and National Association of State 
Budget Officers, 2007).  However, according to the same report, Medicaid costs continue 
to be a high proportion of overall state spending, representing approximately 22% of state 
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budgets.  Chronic diseases contribute significantly to these rising costs.  Eighty-three 
percent of Medicaid dollars and almost all Medicare dollars are spent on beneficiaries 
with chronic illnesses (Partnership for Solutions, 2004). 
Diabetes 
Diabetes prevalence trends and costs have contributed to the growing problem of 
chronic illnesses.  The number of Americans diagnosed with diabetes has more than 
doubled since 1990 with more than 17.9 million diagnosed in 2007 and an estimated 5.7 
million more who remain undiagnosed (Centers for Disease Control and Prevention, 
2009). This number is expected to increase further, doubling the 2009 numbers by 2034 
(American Diabetes Association, 2009). Statistics on causes of death indicate that 
diabetes was the seventh leading cause of death in 2006, with the risk of death for 
individuals with diabetes two times as high than for those without the disease (Centers for 
Disease Control and Prevention, 2009).  Diabetes leads to a broad range of acute and 
long-term complications including heart disease, stroke, hypertension, blindness, 
amputations, and kidney and renal failure. The CDC classified diabetes as “disabling, 
deadly, and on the rise in 2004” (Gerberding, 2005, p. 1).    
The price tag for health care of those with diabetes is significant when compared 
with health care costs of the general population. According to a report by the American 
Association of Clinical Endocrinologists (2007) the annual direct health care costs for 
persons with diabetes are three times those of individuals without diabetes. Projections on 
cost trends indicate that the $92 billion direct cost of diabetes in 2002 is expected to rise 
to $109 billion in 2010 and $138 billion in 2020 (Centers for Disease Control and 
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Prevention, 2009).  The annual cost to Medicare for end stage renal disease attributable to 
diabetes is reported to be approximately $63,000 per recipient (Brandle et al., 2003).  
Despite efforts to control costs and the implementation of programs to address the 
progression of diabetes, costs continue to rise.   
Chronic Illness Management 
Desired Outcomes 
The primary outcomes of interest to individuals with chronic illnesses and other 
stakeholders are improvement in clinical status, avoidance of unnecessary complications, 
prevention of co-morbid conditions and consequently avoidance of the costs associated 
with complications and co-morbidities (Kane, Priester, & Totten, 2005).   Shaughnessy, 
Crisler, Schlenker and Arnold (1997) classified these outcomes as end-result outcomes.  
Programs are implemented to impact these outcomes; however, it is sometimes difficult 
to draw conclusions about elements of an intervention if only end-result outcomes are 
evaluated (Donabedian, 1985).  The concept of intermediate outcomes has been 
introduced to bridge the gap between interventions and improvement in health, 
improvement in quality of life and controlled costs.  Intermediate outcomes are more 
closely linked to the interventions and are steps towards these end-result outcomes.  
Intermediate outcomes include changes in behavior related to the management of a 
disease (Donabedian, 2003).  Adherence behaviors are the intermediate outcomes of 
interest in this research.  Adherence behaviors are influenced by program elements and, 
in turn, influence desired end outcomes.  As attempts are made to impact the health of 
individuals with chronic conditions, the earliest observed outcomes associated with 
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chronic care management interventions are related to adherence behaviors.  Figure 1 
depicts the relationship between interventions, early or direct outcomes associated with 
the interventions, and longer term outcomes associated with the interventions.    
 
Figure 1. Depiction of the Relationship between Interventions, Intermediate and End 
Outcomes  
Adherence 
The World Health Organization (WHO) highlighted the importance of focusing 
on adherence in their publication Adherence to Long-term Therapies
 The WHO (2003) indicated that patient adherence is a primary determinant of 
positive clinical and cost outcomes.  According to the WHO, adherence to treatment 
recommendations leads to a reduction in complications and disease progression and 
consequently improves quality of life.  The WHO report also indicated that costs are 
impacted through adherence to treatment recommendations both directly and indirectly.  
 (World Health 
Organization, 2003).  While there are multiple definitions of adherence the WHO defines 
it as the extent to which an individual’s behavior is consistent with recommendations 
from a health care provider.  Adherence to recommendations usually signals a person’s 
engagement in self-management.  One measurement of adherent behavior involves 
comparison of the services received against what is recommended by evidence-based 
guidelines developed for management of a condition. 
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Improved adherence to recommended guidelines in managing chronic illnesses and 
associated complications results in direct cost savings when expensive health services 
that would have been necessary as the condition progressed are avoided. Costs are 
impacted indirectly by improving quality of life and sustaining vocational roles of 
individuals with chronic conditions, an outcome in which employers are interested.  
Questions often arise as to whether adherence is patient adherence or physician 
adherence. This research makes the assumption that patient adherence is inextricably 
entwined with physician “buy in” to clinical guidelines and support of adherence.  While 
it is acknowledged that this relation exists, it is further assumed that patients are 
responsible for their health.  Measuring adherence then evaluates patient behavior related 
to evidence-based guidelines with physician support.  
Disease Management 
Increasing awareness of the impact of chronic illnesses on individuals, families, 
and society precipitated a search for solutions by the health care industry.  In the late 
1980s and early 1990s the concept of evidence-based medicine developed as an approach 
to provide consistent, research-driven, standardized management of illness, particularly 
chronic illness (Evidence-Medicine Working Group, 1992).  In the 1990s, the American 
Diabetes Association developed national evidence-based guidelines for the management 
of diabetes. These guidelines provide the foundation for effective diabetes management. 
At the same time evidence-based guidelines were introduced, the concept of 
disease management arose as a mechanism to manage chronic conditions (Todd & Nash, 
1997).  Disease management is an attempt to mitigate the effects of chronic conditions. 
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Disease management programs focus on prevention of disease progression and 
complications by utilizing evidence-based guidelines and by empowering individuals to 
effectively manage their disease (Disease Management Association of America, 2007). 
Full service disease management includes six major components:  
1. Population identification processes through which individuals with a condition 
are identified and in some cases risk stratified; 
2. The use of evidence-based practice guidelines to guide the recommended 
services; 
3. Collaborative practice models which include physicians and other providers 
who support the guidelines; 
4. Patient education in self-management;  
5. Measurement of the success of the intervention that include process and 
outcome measures; and   
6. Routine reporting and feedback.  
Since the introduction of disease management, programs have been adopted by 
private insurance companies and managed care organizations as an approach to address 
chronic illnesses.  The main focus of these disease management programs was on 
educating patients on evidence-based guidelines and facilitating self-management.  In 
2003 and 2004, almost 60% of large employers offered disease management programs 
(Glabman, 2005).  Medicare has implemented disease management programs and is 
exploring the impact of a disease management approach on the health of Medicare 
recipients. Two major initiatives established by the Centers for Medicare and Medicaid 
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Services (CMS) have occurred over the past nine years.  In 2000, the Benefits 
Improvement and Protection Act (BIPA) mandated a demonstration program designed to 
evaluate the impact of a disease management approach on improving the health of 
randomly selected individuals with congestive heart failure, diabetes and coronary heart 
disease (Center for Medicare and Medicaid Services, 2003).  The three year 
demonstration project was implemented in early 2004.  In 2003, the Medicare 
Modernization Act authorized another initiative, initially called the Chronic Care 
Improvement Program and changed to Medicare Health Support, to establish eight pilot 
programs for disease management (Center for Medicare and Medicaid Services, 2010). 
In October 2008, the second report of the outcomes from this program was 
published.  Five of the eight organizations originally selected to participate terminated 
their involvement by the time of the report.  The program produced limited effect on 
behavioral change, savings, satisfaction, care experience, and functional status.  One 
finding was that the number and type of contacts was not significant enough to effect 
change   (McCall, Cromwell, Urato & Rabiner, 2008). 
Despite the proliferation of disease management programs, reports indicate that 
receipt of health care services within guideline parameters remains low, placing 
individuals with chronic conditions at risk for the development of complications 
associated with a worsening condition.  According to McGlynn, Asch, Keesey, Hicks, 
and DeCristofaro (2003), only 54.9% of services determined to be quality indicators for 
chronic care were received within established guidelines.  In 2004, the Congressional 
Budget Office (CBO) commissioned an analysis of research on the impact of disease 
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management programs on cost.  The analysis concluded “there is insufficient evidence to 
conclude that disease management programs can generally reduce overall health 
spending” (Congressional Budget Office, 2004, p. 1). The report stated that even in 
instances where there were savings, these resulted from interventions provided in 
controlled settings.  The authors questioned the applicability to larger populations.  
Conflicting reports also surround the effectiveness of disease management programs in 
improving clinical status.  The Employee Benefit Research Institute (Christensen, 2002) 
reported on disease management research related to who implemented programs, reasons 
for implementing programs and the reported impact of the programs on health and costs.  
The report concluded that there is “no conclusive evidence that DM programs, in general, 
improve health or reduce costs in the long term” (p. 4).  
An Alternate Practice Model 
Given the complexities of managing chronic illnesses, a multi-dimensional 
approach has been proposed and a practice model has been developed.  The Chronic Care 
Model (Wagner, Austin, & Vonkorff, 1996) acknowledges the importance of the self-
management support component of disease management programs but proposes that a 
system level approach must be added to improve chronic care.  Self-management support, 
one of the six elements of the model, is combined with organizational factors including a 
health system designed around chronic rather than acute care; a partnership with the 
community for support and education; clinical information systems that help to identify 
patients and provide feedback regarding outcomes; the availability of community support; 
and leadership in the community or organization that supports these changes. 
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Purpose of the Research 
The struggle to identify effective strategies for managing chronic conditions and 
the current short-comings of established programs in impacting adherence to evidence-
based guidelines point to the need for additional research.  What other strategies can 
impact adherence behaviors?  Are approaches that involve broader health system 
interventions necessary before adherence levels change significantly and disease 
progression is slowed or stopped? 
The purpose of this research is to explore the relationship between adherence to 
diabetes guidelines and approaches to diabetes management adopted by two employer-
sponsored self-insured health plans.   The approaches include a traditional disease 
management one in which individual level interventions were used and one in which a 
system level approach containing all the components of the Chronic Care Model (CCM) 
was used.   
Theoretical Framework 
System Level 
Most theories and conceptual models that help to explain the factors impacting 
adherence behaviors focus on interpersonal or individual level factors. These theories, 
further discussed in Chapter 2, explain adherence as a result of increasing an individual’s 
perception of risk and the level of skills needed to address the risks.  Education is the 
major focus of programs using these theoretical approaches.  However, according to the 
World Health Organization (2003), system changes are required to improve adherence 
levels.  One of the system changes addressed by the WHO is the need to move away from 
12 
 
an approach to health care that is episodic and related to acute episodes of need to one 
that focuses on health and wellness along a continuum.    
Ecological Theory 
Social ecology theory (SET) acknowledges that health behaviors are influenced 
by multiple factors at many different levels in an individual’s environment.  The factors 
range from characteristics of the individual, social relationships, characteristics of the 
community and institutions and the presence or absence of policies supporting healthy 
behaviors.  The theory posits that an individual’s health both influences the environment 
in which they function and is influenced by that environment in a reciprocal way.   
Spheres of influence impact the well-being of an individual.  The spheres include those 
individuals and systems with which the patient directly interacts; linkages between those 
individuals and settings; individuals and settings with which the patient does not directly 
interact but which have influence over the patient; and finally the policies, culture and 
context in which the other spheres function. According to SET, since each of the spheres 
influences a person’s health and behaviors, when programs are designed to address the 
health of populations these spheres of influence should be considered.  Such programs 
involve more than patient education.  They are designed to include efforts to change 
organizational behavior, the physical environment and social milieu. (National Cancer 
Institute, 2005). 
Research Questions 
The purpose of this research is to explore the relationship between adherence to 
diabetes guidelines and approaches to diabetes management adopted by two employer-
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sponsored self-insured health plans.   The approaches include a traditional disease 
management one in which individual level interventions were used and one in which a 
system level approach containing all the components of the CCM was used.  The research 
examines the influence of the system level factors in relation to individual level factors 
known to influence health-related behaviors.  The following questions are addressed:  
In relation to individuals with diabetes: 
1. Is there a difference in adherence behaviors between individuals in a health plan 
that implemented a system level program and those in a health plan that 
implemented an individual level program only? 
2. Can adherence to selected evidence-based guidelines be predicted by age, gender, 
co-morbid conditions, number of hospitalizations, evidence of a consistent 
medical provider, and approach to diabetes management (system-level versus 
individual-level only)?  
Significance of the Study 
The major historical initiative to impact outcomes for chronic illnesses has been 
disease management.  Evidence of the impact of disease management programs on 
adherence behaviors is conflicting and inconclusive. Questions remain regarding the 
features of a disease management program that have the greatest impact on adherence.  
Wagner (1997) stated that “Following the failure of health care reform, we are 
experiencing unprecedented, unevaluated tinkering with basic care models and values” 
(p. 702). He called for research to assess the effectiveness of different approaches to 
providing care for the chronically ill.   This research is designed to advance what is 
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known about the management of chronic illnesses by examining the impact of a system 
level approach on adherence to diabetes guidelines and comparing them to the traditional 
approach adopted in most disease management programs.   
Assumptions 
For the purpose of this research, there is no distinction between adherence and 
compliance.  In the literature both terms indicate the receipt of services according to 
clinical recommendations in the patient’s treatment plan. The main distinction between 
the two terms is that adherence implies patient agreement with the treatment plan.  Since 
it is difficult to obtain information on patient agreement where the terms compliance and 
adherence are used they are treated as synonyms.   
There are three different types of diabetes: type 1, type 2 and gestational.  Type 1 
diabetes results from the inability of the body to produce insulin.  Type 2 diabetes results 
primarily from the body’s difficulty in using the insulin that is produced with a secondary 
deficit in production and release of insulin. This study excludes gestational diabetes since 
this type is generally self-limited and disease management programs for individuals with 
gestational diabetes focus on all the clinical needs of pregnant women at risk. The 
majority of individuals diagnosed with diabetes suffer from type 2 (Center for Disease 
Control and Prevention, 2005).  While the pharmaceutical approaches to the different 
types of diabetes may be different, the American Diabetes Association (ADA) guidelines 
for the four areas of interest of this study are the same for type 1 and type 2 diabetes.  
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Definition 
 Adherence is a complex concept but the definition presented by the WHO 
is one that is often referenced in literature (Bissonnette, 2008;  Bosworth, Oddone & 
Weinberger, 2006; Pathman, Konrad, Freed, Freeman & Koch, 1996).  Adherence 
behaviors are those behaviors that indicate engagement in following clinical guidelines 
for frequency and type of care.  Adherence in diabetes management includes: obtaining 
lab work at recommended frequencies and obtaining screening services for disease 
progression, such as retinopathy and nephropathy.     
Summary 
Federal and state governments and private insurers are struggling with managing 
the complications associated with chronic illness and the rapidly rising costs associated 
with them. Disease management is one approach that has gained increasing popularity 
over the past decade.  However, two issues with the current approach have been 
identified in the literature.  First, results from previous studies are inconclusive on the 
impact of disease management programs and low adherence to guidelines is still being 
reported.  Secondly, it has been proposed that system wide interventions may need to 
occur in order to support chronic illness management.  
This research explores the difference in adherence behaviors between individuals 
enrolled in a health plan that provides traditional disease management and those enrolled 
in a system-level program.  It is hoped that this research will help to identify strategies to 
ameliorate the burden of chronic disease.    
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Organization of the Study 
The remainder of this study is organized into four additional chapters, references 
and appendices.  Chapter 2 presents theoretical foundations for understanding behavioral 
change.  It also presents the literature that addresses the current body of knowledge on the 
impact of adherence behaviors in the management of chronic diseases and methods taken 
to improve adherence. Chapter 3 delineates the research design and methodology.  It 
defines the sample for the study, the characteristics of the study groups and the data 
collection instruments to be used.  Chapter 4 contains the results of the analysis. Chapter 
5 provides a summary, discussion of the findings and recommendations resulting from 
the study.  Chapter 5 is followed by a bibliography and appendices.   
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CHAPTER 2: LITERATURE REVIEW 
 
Purpose Statement 
The purpose of this research is to explore the relationship between adherence to 
diabetes management guidelines and diabetes management programs implemented by 
two health plans.  The subjects are individuals with diabetes who are covered under one 
health plan that has implemented a system level program to address chronic illness care 
and individuals covered under one health plan that has not implemented a system level 
program but rather a traditional individual level program.  The study determines whether 
there is a significant difference in adherence between the two groups two and a half years 
after the implementation of the chronic care programs.  In addition, the study explores 
whether the type of approach to diabetes management is predictive of improvement in 
diabetes-related adherence behaviors.   
Introduction 
This literature review provides a brief overview of the significance of adherence 
in relation to improving health outcomes for individuals with chronic illnesses 
particularly diabetes.  A brief overview of theories of behavioral change is presented.  
The review continues with an exploration into what is currently known about approaches 
to managing diabetes and improving adherence to diabetes management guidelines.  
Individual level approaches are examined as well as recent developments in models for 
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chronic care management that propose a system-level approach to improving chronic 
condition management.  The chapter concludes with a presentation of recent research in 
system-level approaches.   
The Concept of Adherence 
Adherence is a complex concept.  In the literature there are multiple definitions 
reflecting different levels of patient involvement in the decision to engage in health-
related behavior (Bosworth, Oddone & Weinberger, 2006; Hearnshaw & Lindenmeyer, 
2005; Helvi Kyngas Kyngae, 2000).   Terms that are used to signify adherence are 
compliance, self-care, self-management, concordance, acceptance and obedience 
(Bissonnette, 2008; Evangelista, 2008). Adherence involves the adoption of behaviors 
that are consistent with recommendations for appropriate health management.   
Multiple factors impact adherence behaviors such as health perceptions; 
individual characteristics such as coping styles; social circumstances such as supportive 
resources; knowledge; past success in improving health behaviors; the quality of the 
patient-provider relationship; treatment; and, disease characteristics (Sherbourne, Hays, 
Ordway, DiMatteo and Kravitz, 1992; World Health Organization, 2003).  Different 
models of adherence are presented in the literature. One model presents three steps 
towards adopting adherence behaviors.  In order to adopt the required behavior the 
patient begins with awareness of the behavior and an understanding of the importance of 
adopting the behavior.  The patient then moves towards agreement to engage in the 
behavior and initially engages in the behavior.  Finally, the patient proceeds to 
consistently demonstrate sustained adherence (Pathman, Konrad, Freed, Freeman & Koch, 
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1996).  The medication adherence model presents two concepts associated with 
adherence behavior.  The first is purposeful action, the extent to which an individual 
engages in a select behavior.  The next is patterned behaviors, which is the extent to 
which an individual adopts a habit of engaging in the health-related behavior (Johnson, 
2002). The precaution / adoption process model posits that the process involved in 
adhering to health-related behaviors involves four general steps (Bosworth, Oddone & 
Weinberger, 2006). The individual becomes aware of the need to perform the behavior; 
forms the intention to adopt the behavior; acts (or decides not to act); and maintains the 
behavior.  
The Significance of Adherence 
Adherence is the key link between recommended therapies and positive clinical 
outcomes (Kravitz and Melnikow, 2004).  The WHO recognized the significance of 
adherence in impacting overall health and commissioned a publication on the topic 
(World Health Organization, 2003).  The publication called for a focus on adherence, 
indicating that measurement of adherence helps in identifying and refining effective 
interventions.   
The Significance of Adherence to Diabetes Guidelines 
In relation to diabetes, the WHO indicated that adherence behaviors such as self-
monitoring of blood glucose and receipt of the necessary screenings have been linked to a 
lower incidence of complications and a slowing of disease progression among diabetics 
(World Health Organization, 2003).   Sloan, Bethel, Lee, Brown, and Feinglos (2004) 
examined the impact of adherence to screening guidelines on hospitalizations in 
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Medicare patients with diabetes.  The authors concluded that there was a significant 
association between high rates of adherence and lower rates of hospitalizations for 
complications of diabetes.  McGlynn, Asch, Keesey, Hicks, and DeCristofaro (2003) 
reported on quality in relation to diabetes care; identified gaps in adherence to basic 
diabetes care; and emphasized the need to develop strategies to reduce these gaps that 
threatened the health of the American public.     
Adherence to Hemoglobin A1c Monitoring 
Hemoglobin A1c (HbA1c) is a measure of a patient’s glucose level over the two 
to three months prior to the test.  The American Diabetes Association recommendation 
for frequency of monitoring HbA1c is every six months for all individuals whose 
diabetes is well controlled and every quarter for those individuals whose diabetes is not 
well-controlled and whose glucose levels are not within target range (American Diabetes 
Association, n.d.).   
Monitoring glucose levels as recommended is seen as important because 
controlled glucose prevents or delays the onset of complications associated with diabetes 
(American Diabetes Association, n.d.). There are correlations between elevated A1c and 
cardiovascular diseases such as silent myocardial ischemia (DeLuca, Saulle, Aronow, 
Ravipati, & Weiss, 2005); coronary artery disease (Ravipati, Ahn, Sujata, Saulle, & 
Weiss, 2006); and peripheral artery disease (Selvin, Wattanakit, Steffes, Coresh, & 
Sharrett, 2006).  In addition, elevated glucose levels are associated with microvascular 
changes that lead to complications such as diabetic retinopathy and kidney disease 
(Blonde, 2007; The Diabetes Control and Complications Trial Research Group, 1993).   
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According to the National Diabetes Information Clearinghouse (2005), every one point 
drop in A1c level corresponds with a 40% decrease in the risk for complications 
associated with microvascular changes.  The significance of these linkages between 
glucose levels and diabetes complications highlights the importance of frequent 
monitoring of patients’ A1c.   National adherence levels for individuals who have had at 
least two A1c tests per year have ranged from 64.3 to 68.8% from 2000 to 2005, the most 
recent data available (Centers for Disease Control, 2007).     
Adherence to Cholesterol Screening 
Cholesterol levels out of the acceptable range in patients with diabetes have been 
shown to be significantly correlated to atherosclerotic changes and predictive of cardiac 
events associated with atherosclerotic changes (American Heart Association, 2007; 
Drexel, et al., 2005).  Heart disease presents a significant risk to individuals with 
diabetes.  In fact, 65% of deaths in patients with diabetes are associated with heart 
disease and stroke (American Diabetes Association, 2007).  For patients with diabetes, 
lowering LDL cholesterol can reduce the risk of heart attack by 42% (American Heart 
Association, 2007).  Standards for diabetic care include the use of lifestyle changes and 
lipid lowering medications in patients with diabetes and coronary heart disease.  These 
treatments are thought to be effective in lowering the risk of mortality, recurrent 
myocardial infarction, and stroke.  Diabetic standards of care recommend at least yearly 
monitoring of lipid levels in order to detect dyslipidemia early, treat early and prevent the 
development of diabetes complications (American Diabetes Association, 2007).  No  
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national trend information is available for rates of cholesterol monitoring in individuals 
with diabetes.  
Adherence to Retinopathy Screening 
Diabetes is the leading cause of new cases of blindness in adults and leads to 
12,000 to 24,000 new cases of blindness every year (American Diabetes Association, 
2007).  Diabetes retinopathy, a condition caused by blood vessel damage caused by 
diabetes, progresses from non-proliferative to proliferative, leading to blindness.  This 
progression can occur without the patient’s awareness (The American Diabetes 
Association, nd). There are treatments available to prevent or delay the onset of diabetic 
retinopathy, thereby preventing loss of vision (The American Diabetes Association).  
Early detection leads to early intervention and can lead to the prevention of blindness and 
visual impairment.  Screening for diabetic retinopathy by an ophthalmologist or an 
optometrist is recommended yearly for individuals with diabetes type 2 when first 
diagnosed and three to five years after diagnosis for patients with diabetes type 1 (The 
American Diabetes Association, 2007).  National rates of adherence to annual retinopathy 
screening have ranged from 56.8% in 1996 to 66.5% in 2001.  There has been a decline 
in adherence since 2001.  In 2005, the latest results available, the national adherence rate 
was 60.6% (Centers for Disease Control, 2007). 
Adherence to Nephropathy Screening 
The prevalence of chronic kidney disease continues to rise, with a reported 40% 
increase since the 1988 to 1994 data was collected (The United States Renal Data 
System, 2007).   Diabetes is the most common cause of chronic kidney disease and 
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subsequent kidney failure.  It occurs in 20 – 40% of patients with diabetes (The American 
Diabetes Association, 2007, p. S19).  Almost 45% of all newly diagnosed cases of kidney 
failure are attributed to diabetes (National Kidney and Urologic Disease Information 
Clearinghouse, 2008). Untreated chronic kidney disease results in kidney failure and 
ESRD, leading to dialysis, transplantation or death. Significant complications are 
associated with dialysis and transplantation and individuals with diabetes are at a higher 
risk for these complications.  The combination of diabetes and end-stage renal disease 
(ESRD) leads to higher rate of cardiac decompensation, sepsis and pulmonary disease 
than with other diseases.  These serious complications lead to a higher death rate for 
patients with diabetes (Friedman, 2007).  If detected early, treatments can be initiated that 
slow the rate of kidney disease and the progression to ESRD.  Annual screening for the 
presence of microalbuminuria is recommended for individuals with type 1 diabetes five 
years after diagnosis and for individuals with type 2 diabetes at the time of diagnosis.  No 
national trend information is available for rates of nephropathy monitoring in individuals 
with diabetes. 
Improving Adherence 
Adherence outcomes in relation to programs implemented to address the needs of 
individuals with chronic conditions have received mixed reviews in the literature over the 
past several years.  Some reviews reported a slight improvement in adherence to diabetes 
management guidelines (Agency for Health Care Research and Quality [AHRQ], 2006; 
National Committee for Quality Assurance, 2007).  At the same time CDC statistics 
showed a slight decrease in adherence to some of the guidelines and an increase in co-
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morbid conditions such as renal and cardiac disease (Centers for Disease Control, 2007).  
Even those reports that showed an improvement in adherence acknowledged that 
improvements were slight and additional efforts are needed to aggressively attack the 
problem of poor adherence to guidelines for the management of chronic conditions (The 
Agency for Health Care Research and Quality [AHRQ], 2006).   
Theoretical Understanding of Adherence Behaviors 
Research in the management of chronic disease in relation to adherence behaviors 
has rarely been presented within the context of a theoretical perspective.  Understanding 
the relationship between theories and models of behavior change and adherence 
behaviors may lead to a greater understanding of what works to improve adherence 
behaviors in individuals with chronic conditions.  According to Patterson (2001), 
“Theories can guide the search to understand why people do or do not follow medical 
advice, help identify what information is needed to design an effective intervention 
strategy, and provide insight into how to design a successful educational program” (p. 27).  
Most approaches to improving adherence have focused on individual level factors and 
most theories of behavior change focus primarily on individual behavior change 
processes, not system level factors (Grizzell, 2003).   
Approaches to Improving Adherence 
Individual Level Theories of Behavior Change 
Theories and conceptual models that help in the understanding of individual level 
factors associated with behavior change include the Health Belief Model, the 
Transtheoretical Theory, the Theory of Planned Behavior, and a model called the  
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Information-Motivation-Behavioral Skills Model (IMB).  It is important to understand 
these theories since individual level factors are among the factors that influence behavior 
change.  
The Health Belief Model (HBM) focuses on several precursors to taking action to 
improve one’s health.  According to Glanz, Lewis, and Rimer (1997), the HBM has its 
root in expectancy theory.  A basic tenet of the theory is that an individual desires to be 
healthy and to avoid illness. Belief that a specific action will prevent an illness leads the 
individual to adopt a particular behavior.  The HBM focuses on ways in which one’s 
belief can be changed.  Through its focus on how beliefs can be changed, the HBM 
provides an understanding of how preventive behaviors can be stimulated by specific 
motivational factors.  It posits that individuals perceive their susceptibility or risk in 
relation to their health and the seriousness of not taking preventive action.  Modifying 
factors within the HBM point to internal and external factors that impact each 
individual’s perception of risk.  Cues to action are additional modifying factors that 
increase the perception of risk and the likelihood of adopting the desired behavior.  In 
addition to the perceived susceptibility and the perceived risk in the Health Belief Model, 
the individual also needs to perceive a benefit to taking the action. Perceived barriers also 
must be identified and addressed in order for the action to be taken. Because the model 
deals with individual perception the HBM focuses primarily on knowledge and education 
as the main cues to action.  Programs informed by this model of behavior change are 
designed to increase the individuals’ perception in all these areas.  An individual will be  
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educated regarding the risk, the susceptibility and the benefits in order to move them to 
action.  Skills to address the barriers are developed. 
One of the most widely cited theories for behavioral change is the 
Transtheoretical Theory.  This theory, posed by Prochaska and DiClemente (1983), 
presents the concept of a staged process of behavioral change.  The stages represent a 
continuum and address readiness to change a behavior that is contributing to poor health.  
There are five stages of change: pre-contemplation; contemplation; preparation; action; 
and maintenance. This readiness to change theory is used in many health promotion 
programs.  Programs framed in this theory focus on evaluating the individual’s readiness 
and based on that readiness the individual is educated in the skills necessary to succeed in 
each stage and move along to the next one. Self-management skills are taught in the 
action and maintenance stage. 
Glanz, Lewis, and Rimer (1997) indicated that the Theory of Planned Behavior 
posits that behavior change is immediately preceded by an intention to change.  This 
intention is modified by: 1) belief about the likely consequences of adopting the behavior 
or not adopting it (behavioral beliefs); 2) belief about societal or other person’s 
expectations in relation to adopting the behavior (normative beliefs); and, 3) perceived 
control over the behavior (control beliefs) (Ajzen, 2002).  The combination of these 
beliefs impacts the individual’s intention to perform the behavior, which then impacts the 
performance of the behavior.  In general, a behavior is more likely to be performed when 
beliefs are strong about the consequences of performing the behavior, about others’ 
expectations, and about the individual’s perception of ability.  Programs framed and 
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informed by this theory focus on increasing an individual’s beliefs about the 
consequences of performing or not performing the behavior.  Support is coordinated for 
the individual in the performance of the behavior and expectations of the health 
professional are conveyed regarding the health-related behavior.  Self-management skills 
education and support are also components of such programs.  
DiClemente, Crosby, and Kegler (2002) presented another theory in health 
promotion, the Information-Motivation-Behavioral Skills Model (IMB).  Although the 
IMB has been primarily used in HIV prevention, it has been presented as a model for 
other health behaviors as well. Three basic skill sets are proposed as determinants of 
adopting and performing preventive behaviors.   Informational skills are enhanced by 
providing information related to the condition and associated with the desired behaviors.  
Motivational skills are enhanced by conveying information on risk level and personal 
susceptibility and also by improving perception of available social support.  Behavioral 
skills are enhanced by addressing the individual’s ability and perceived ability to perform 
the sequence of behaviors required. Programs framed by this model disseminate 
educational materials that are designed to provide facts that are easy to translate into 
action.   
Individual Level Approaches to Improve Adherence to Diabetes Guidelines 
Much of the literature in the 1990’s and early 2000’s related to the management 
of chronic conditions focused on disease management programs.  Programs for the 
management of chronic conditions in the current nomenclature of disease management 
came to the surface in the late 1980’s at the Mayo Clinic.  More attention was drawn to 
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disease management as a formalized program in the early 1990’s, when the Mayo Clinic 
and the John Deere Health Plan joined to build a clinic and establish programs designed 
to address the needs of individuals with chronic conditions (Todd & Nash, 1997).  In the 
1990’s pharmaceutical companies were instrumental in providing disease management 
services; disease management organizations were developing; and there was wide 
adoption of the concepts of disease management by the payers of health care (Matheson, 
Wilkins, & Psacharopoulos, 2006).  According to the literature describing the elements of 
disease management, some common characteristics are: self-management education and 
empowerment; the use of evidence-based guidelines to educate and to measure outcomes; 
feedback to providers on the patient’s progress related to evidence-based guidelines; and, 
engagement with physicians in the management of chronic conditions (Congressional 
Budget Office, 2004; Disease Management Association of America, 2007).   
Disease management programs reported in the literature are rarely presented from 
a theoretical perspective.  Most of these programs approach chronic illness management 
from an individual factor level.  The most frequently reported approaches to the 
management of diabetes are self-management education and support.  Self-management 
education and support incorporate many of the individual-level components of behavioral 
change theories.  Self-management education is designed to increase a patient’s 
knowledge of the specifics of the disease, possible complications, consequences of poor 
management (providing a cue to action), and the components and rewards of effective 
management.  Self management support is designed to reinforce appropriate behavior.   
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Self management education for the majority of disease management programs 
involves the mailing of educational material and reminders regarding guidelines (Espinet, 
Osmick, Ahmed, & Villagra, 2005; Gold & Kongstvedt, 2003; Shojania et al., 2006; 
Steffens, 2000; Guadagnino, 2005). In addition to mailing educational materials some 
programs offer support by providing monitoring devices such as blood glucose devices 
that are uploaded to a central database for clinicians to review (Kim, Yoo & Shim, 2005; 
Hensley, Jones, Williams, Willsher, & Cain, 2005; Villagra & Ahmed, 2004).  On-site 
diabetes education classes and group support are included in some disease management 
approaches (Clancy, Huang, Okonofua, Yeager, & Magruder, 2007; Nolte, Elsworth, 
Sinclair, & Osborne, 2007; Peters & Davidson, 1998; Stern, 2005). Web-based 
educational programs have been developed and adopted as another approach to 
improving overall management of diabetes (Lorig, Ritter, Laurent, & Plant, 2006; 
McMahon et al., 2005; Meigs et al., 2003).  Often more intense interventions are 
implemented to provide support based on a patient’s level of risk for complications.  
Individuals at higher risk are offered more intense interventions such as on-site and/or 
telephonic interactions by nurses who provide education, reinforce education, provide 
feedback on progress and coordinate needed resources (Domurat, 1999; Espinet, Osmick, 
Ahmed, & Villagra, 2005; Fireman, Bartlett, & Selby, 2004; Guadagnino, 2005; 
Halderman, Read, & Hart, 2001; Steffens, 2000;Thomson Healthcare Company, 2005).   
Involvement of the treating physician is also seen as an essential component of 
any program designed to address the needs of individuals with chronic conditions 
(Disease Management Association of America, 2008).   Rothman & Wagner (2003) point 
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to the role of the primary care provider in the care of individuals with diabetes, indicating 
that the patient looks to a person who has the ability to coordinate across disciplines and 
who can provide more holistic care.  The primary care provider meets these 
characteristics.  The strength of the patient–provider relationship is also cited as an 
important factor for the realization of positive outcomes in the management of chronic 
illnesses (Ciechanowski, et al., 2004; Maddigan, Majumdar & Johnson, 2005).   
Adherence Outcomes of Individual Level Approaches 
The varying results reported by programs focusing on individual level disease 
management interventions have caused a number of experts to question the effectiveness  
of this approach. Outcomes reported on these programs include cost, clinical, and 
adherence factors.  Since adherence is the focus of this research, literature on individual 
level approaches and their impact on adherence is presented.  Table 1 provides a 
summary of the literature and details of the research follows.    
Traditional large scale diabetes disease management programs involve phone 
calls to patients; educational materials sent to patients and families; phone calls to remind 
patients of appointments or when preventive tests are due; mailings to physicians 
regarding evidence-based guidelines; and feedback to physicians on how their patients 
are performing against these guidelines.    In 1998, the John Deere Company 
implemented a large scale study of the disease management program implemented in the 
early 1990s.  There were approximately 20,000 John Deere Health Plan participants with 
diabetes, the study evaluated half of these participants (N=10,000) who were enrolled in 
the diabetes management program. Results of the program were published in 2000 
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Table 1. Summary of Research on the Impact of Individual Level Approaches on 
Improving Adherence in Patients with Diabetes 
 
Program 
Intervention 
Reference Theory N Outcomes 
Phone calls and 
educational 
mailings; 
reminders; and 
feedback to 
physicians  
Steffens, 2000 No theoretical 
foundation 
presented 
10,000 After one year, 
screening rates for 
HbA1c, lipid levels 
and nephropathy 
risk were reportedly 
significantly 
improved. 
No statistical 
significance was 
reported. 
Telephonic and 
mailed interactions 
as well as some 
face-to-face contact 
designed to 
increase knowledge 
and self-
management skills. 
 
Tested participation 
primarily 
Espinet, 
Osmick, 
Ahmed, & 
Villagra, 2005 
No theoretical 
foundation 
presented 
7,000 HgbA1c testing, 
lipid testing, 
retinopathy exams 
and nephropathy 
screening - 
Statistically 
significant 
improvement in 
adherence scores 
over those who 
partially participated 
and those who did 
not participate (p < 
0.001).   
A computer 
tracking system 
that was used to 
facilitate team care 
of patients with 
diabetes.  The 
intervention group 
was the patients 
with highest risk. 
Domurat, 
1999 
No theoretical 
foundation 
presented 
10,000 Significantly better 
adherence to 
HgbA1c, lipid tests 
and nephropathy 
screening (p < .001). 
The risk level of the 
participant could 
have impacted the 
improvement in 
adherence rather 
than the 
intervention. 
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Table 1, continued 
 
Program 
Intervention 
Reference Theory N Outcomes 
Comparison of 3 
approaches: regular 
clinic visits, an 
additional one-time 
education class, the 
addition of a 
telephonic case 
manager 
Howe, et al., 
(2005) 
Transtheoretical 
theory 
75 Adherence in the 
education and case 
management group 
was significantly 
better compared to 
the standard care 
group (p = .0006).  
No information on 
the exact areas of 
adherence.  
On-site diabetes 
education classes 
and group support 
were provided 
monthly for one 
year 
Clancy, 
Huang, 
Okonofua, 
Yeager, & 
Magruder, 
2007 
No theoretical 
foundation 
presented 
186 Adherence to 
HbA1c, Lipid 
screening, 
retinopathy 
screening and 
nephropathy 
screening were 
measured.  
Retinopathy 
screening was the 
only statistically 
significant result.  
A pharmacist 
intervention in 
which subjects met 
with a pharmacist 
who established a 
care plan.  Follow 
up meetings 
occurred weekly. 
Odegard, Goo, 
Hummel, 
Williams, & 
Gray, 2005 
No theoretical 
foundation 
presented 
77 No improvement in 
the intervention 
group and instead 
the control group 
consistently 
reported statistically 
significant 
improvement in 
adherence 
 
33 
 
Table 1, continued 
 
Program 
Intervention 
Reference Theory N Outcomes 
Studied the 
influence of 
attachment style on 
self-care for 
patients with 
diabetes  
Ciechanowski, 
et al. (2004)  
Attachment 
theory 
4,095 Greater patient-
provider 
collaboration was 
significantly 
associated with 
adherence to diet (p 
< .001) and exercise 
(p < .001).  
Studied the effect 
of patient 
perception of their 
relationship with 
their provider on 
adherence 
Maddigan, 
Majumdar & 
Johnson 
(2005)  
No theoretical 
foundation 
presented 
372 Positive perceptions 
of the patient-
provider 
relationship were 
significantly 
associated with 
adherence to diet (p 
< .05) and exercise 
(p < .05) 
 
(Steffens, 2000).  Some program participants received an educational approach designed 
to raise their awareness of their diabetes and to encourage them to engage in self-
management.  Individuals who had certain levels of risk, such as those who were newly 
diagnosed; those who had recently been hospitalized for diabetes complications; or those 
who had significant co-morbid conditions,  were provided with more intense 
interventions and support by a case manager.  After one year, screening rates for HbA1c, 
lipid levels and nephropathy risk were reportedly significantly improved although no 
statistical significance was reported.  The report did not present results for each of the 
two types of interventions so it is difficult to draw conclusions  on whether the mailing of 
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reminders and newsletters had as much of an impact as the more intense one-on-one 
support for the higher risk population.   
A study of over 7,000 participants in a national diabetes program was conducted 
to determine the impact of program participation on adherence to the recommended 
screenings (Espinet, Osmick, Ahmed & Villagra, 2005). The program was implemented 
in 20 health plans associated with one managed care organization.  The main goal of the 
program was to measure the subjects’ adherence outcomes based on participation in the 
program.  The measures included adherence to HbA1c, lipid testing, nephropathy 
screening, and retinopathy screening.  Adherence to these screenings for three groups was 
compared.  The three groups were those who were engaged in the program for different 
lengths of time or chose not to engage.  The groups were labeled as groups with full 
participation, partial participation and no participation.  Interventions were individual 
level.  Patients were contacted by phone and by mail to provide education on diabetes and 
tools for self-management.   Physicians were provided with feedback on their patient’s 
adherence.  Adherence to HgbA1c testing, lipid testing, retinopathy exams and 
nephropathy screening was measured through a retrospective review of a 12 month study 
period.  Those patients who fully participated in the program showed statistically 
significant improvement in adherence scores over those who partially participated and 
those who did not participate (p < 0.001).  Adherence rates were reportedly better for 
partial participants than for non-participants although the results were not statistically 
significant (p = 0.108).  This research was designed to study the impact of program 
participation on adherence since one of the limitations of disease management programs 
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is participation.  Low participation in disease management programs has been reported 
with only a 7% continuing participation rate after 12 months (Lynch, 2006). The 
investigators concluded that program participation was an important factor in improving 
adherence to recommended screenings.   
A few other research reports show varying degrees of improvement in adherence 
to recommended screenings.  A study of the impact of a diabetes care program 
implemented by Kaiser Permanente compared adherence rates for individuals enrolled in 
the program (n = 2617) versus those who received usual care from their primary care 
physicians (n = 5993).  Individuals involved in the program are those who are at the 
highest level of risk, defined by the author as those who had multiple hospitalizations, 
complications or co-morbidities; newly diagnosed with diabetes; and poor understanding 
of self-care.  The intervention group received support from a team of clinical staff 
including endocrinologists, nurse practitioners, physician assistants, and pharmacists.  
Individuals in the program visited with a single clinician; had group visits and classes, 
and received telephone follow-up providing education and support.  The intervention 
group showed significantly better adherence to HgbA1c, lipid tests and nephropathy 
screening (p < .001) (Domurat, 1999).  However, awareness of risk could have had a 
significant influence on improved adherence rather than the intervention.   
A comparison of three approaches to managing diabetes was reported by Howe, et 
al., (2005).  The three approaches were standard care (four times a year clinic visits); 
standard care plus a one-time education class; and standard care with a one-time 
education class with telephone case management added.  Results in relation to clinical 
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improvement, knowledge and adherence were reported.  After six months no statistically 
significant difference in the HgbA1c results or the level of knowledge between the three 
groups was found.   An adherence score was obtained using a clinician checklist that 
evaluated diabetes adherence behaviors in relation to problem-solving skills and safety 
involving self-management.  Adherence in the education and case management group 
was significantly better compared to the standard care group (p = .0006). There is no 
specific information on the exact areas of adherence.  The authors report, however, that 
content validity was established.   
A two-group comparison study was conducted at an Adult Primary Care Center 
serving minority patients (Clancy, Huang, Okonofua, Yeager, & Magruder, 2007).  The 
two groups were a standard of care group whose members received regularly scheduled 
care delivered by academic internal medicine physicians, residents and nurse 
practitioners and those selected into the intervention group who received group visits.  
The group visits occurred monthly for a year and provided education on diabetes and 
opportunities for support and socialization.  The patients were those with poorly 
controlled diabetes defined as having a HgbA1C greater than 8%.  While the authors 
indicated that patients who attended group visits were more likely to have adhered to the 
recommended screening for diabetes there was only one statistically significant result 
(HgbA1C p = .1193, Cholesterol p = .0815, Microalbumin p = .5119, and eye exams p = 
.0171). The research spanned a time period of 12 months.  
A study of a pharmacist intervention provided at eight primary care clinics was 
conducted (Odegard, Goo, Hummel, Williams, & Gray, 2005).   The goal of the study 
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was to determine whether patients with diabetes who received focused education by 
pharmacists had better adherence scores than those individuals who received usual care.  
Usual care was defined as continuation of care by the patients’ primary care providers.  
The pharmacists in the intervention group worked with the patients to develop an 
individual plan of care and provided the patients with education on diabetes and feedback 
on their progress.  The program lasted for six months and self-reported adherence 
behaviors were measured at six and twelve months.  There was no improvement in the 
intervention group and instead the control group consistently reported statistically 
significant improvement in adherence throughout the 12 months (p = 0.003).  
Two studies reported on the link between the patient-provider relationship and 
adherence outcomes related primarily to exercise and diet.  While these studies do not 
address adherence behaviors that are of interest to this research, they are included here 
because they present results that indicate the patient-provider relationship may be a 
significant variable associated with improved adherence behavior.  Ciechanowski, et al., 
(2004) studied the influence of attachment style on self-care for patients with diabetes 
(4095 subjects).  The primary variable of interest was attachment style.  The authors 
measured the patient-provider relationship by determining the patient’s perception of the 
degree to which the provider collaborated with them.  Greater patient-provider 
collaboration was significantly associated with adherence to diet (p < .001) and exercise 
(p < .001).  Maddigan, Majumdar & Johnson (2005) measured the patient-provider 
relationship using two indicators from the Diabetes Lifestyle Form.  The indicators 
measured patient perception of their relationship with their provider.  As with the 
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Ciechanowski, et al. (2004) study positive perceptions of the patient-provider relationship 
were significantly associated with adherence to diet (p < .05) and exercise (p < .05).  
While there were no studies that report on the impact of age and gender on 
adherence to the diabetic screenings, there are studies that report on adherence to other 
health-related behaviors for diabetes and the correlation between those and age and 
gender.  The results are conflicting, however. In relation to other adherence measures 
such as medication administration and diet for glucose control, gender was associated 
with improved adherence in some of the literature (Hertz, Unger, & Lustik, 2005; Korbel, 
Wiebe, Berg, & Palmer, 2007; McCullum, Hansen, Lu, & Sullivan, 2005) and was not 
associated with adherence in others  (Hartz, et al., 2006; Toljamo & Hentinen, 2001). 
Where there was a difference in adherence associated with gender, females were less 
likely to adhere. In relation to age, there are also varying results associated with 
adherence. Hartz, et al. found that age was inversely associated with adherence to glucose 
monitoring, medication administration and following a recommended diet. However, 
Hertz, Unger, & Lustik, found that younger individuals were more likely to discontinue 
medications for diabetes.    
Limitations of Individual Level Theories and Approaches 
DiClemente, Crosby & Kegler (2002) noted that individual level theories such as 
those delineated earlier in this chapter (the Health Belief Model, the Transtheoretical 
Theory, the Theory of Planned Behavior and the Information-Motivation-Behavioral 
Skills Model) have been dominant in health promotion efforts.  The reason for this 
dominance is that individual-level theories: 
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1. Correctly place the individual as the key decision maker in relation to their 
health. 
2. Assume that people value health and are therefore motivated to improve health 
and prevent illness. 
3. Assume that beliefs and attitudes drive individuals towards the health-related 
behavior. 
Although the importance of placing health care decisions in the hands of the patients is 
acknowledged, researchers have questioned whether individual-level approaches would 
lead to significant and sustained changes in health-related behaviors (DiClemente et al., 
2002).  
 Meta-analyses of diabetes disease management research have identified problems 
with the quality of the studies (Knight et al., 2005; Norris, Engelgau, & Narayan, 2001; 
Vermeire et al., 2005).  Unclear descriptions of interventions make it difficult to draw 
conclusions about what factors may impact adherence (Knight et al., 2005).  Improved 
clinical and adherence outcomes are modest (Knight et al.) or conflicting (Knight et al., 
2005; Norris, Engelgau, & Narayan, 2001; Norris et al., 2002; Vermeire et al., 2005).  
After reviewing research on adherence outcomes of individual level interventions, 
Vermiere et al (2005) concluded that, despite the reported efforts to improve adherence in 
patients with diabetes, no significant improvement nor harm was documented (Vermeire 
et al., 2005).  
 Chronic illness management interventions have primarily focused on impacting 
individual level factors.  The failure of these programs to demonstrate positive clinical 
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and adherence outcomes has lead to explorations into other approaches.  In an attempt to 
discover what will work most effectively in the management of chronic illnesses Wagner 
(1997) called for other focused health services research. The author emphasized that 
patients with chronic illnesses are at risk particularly because some of the programs that 
have been implemented to address chronic illnesses disrupt already established 
relationships with health care professionals.  The author also points out that patients with 
chronic illnesses will benefit greatly if deficiencies in the established approaches are 
corrected.   
A System Level Theory of Behavioral Change: Social Ecological Theory 
Ecological approaches to behavioral change assign as great an importance to the 
creation of supportive environments and on the reorientation of the health system as on 
the development of personal skills. These theoretical approaches have been evolving over 
time from public health and psychological traditions (Glanz, Lewis, & Rimer, 1997).   A 
social ecological approach gives significant weight to the individual’s environment 
including the social, institutional and cultural aspects of that environment (Jamner & 
Stokols, 2000).  Jamner & Stokols presented the core assumptions within Social 
Ecological Theory as applied to health: 
1. The health of an individual is influenced by many factors in the physical 
environment (i.e. geography and technology) and in the social environment (i.e. 
as economics and culture). 
2. Health is influenced by personal factors, including genetics, psychology and 
behavior patterns. 
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3. The environment is multidimensional and complex. 
4. Because of these multidimensional factors, interventions need to involve 
individual, interpersonal and social strategies.  
The authors noted that “…simple appeals to individuals may not be effective since they 
constitute only one influence on the choice to be made…” (p. 41-42).     
Social ecological theory provides insight into the multidimensional factors that 
impact behaviors and it is useful in guiding the development of programs whose goal it is 
to improve health-related behaviors.  It focuses on the multiple levels of influence and the 
interdependence between those levels as well as the individual level influences 
(Grzywacz, 2000; McLaren & Hawe, 2005).  As shown in Figure 2, ecological models 
place the individual at the center with concentric or nested circles around the individual 
representing different levels of environmental influences. The circles widen as they 
extend away from the center and represent the microsystem which is the individual’s 
most immediate context; the mesosystem represents the linkages between the different 
settings in which an individual directly interacts; the exosystem represents linkages 
between systems that impact the individual, but with which the individual does not 
directly interact; and the macrosystem is the overall context in which the micro -, meso – 
and exo-systems function (Bronfenbrenner, 1979; Fisher et al., 2005; Grzywacz, 2000; 
McLaren & Hawe, 2005). 
Social ecology theory has formed the basis of research on programs designed to 
impact changes in health-related behaviors.  A social ecology perspective was used in a  
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Figure 2. Multilevel System Depiction of Social Ecology Application 
program that was designed to develop guidelines for best practices in smoking cessation 
(Hopkins, Husten, Fielding, Rosenquist & Westphal, 2001; Patrick, Intille & Zabinski, 
2005). Multifaceted approaches have been seen as being successful in impacting smoking 
cessation and sustaining healthy behaviors over time.  Individual level assessment, 
education and assistance in the development of strategies to quit were seen as effective 
MACROSYSTEM: policy, 
culture, social context, 
laws 
EXOSYSTEM: linkages 
between settings that the 
individual may not directly 
interact with 
MESOSYSTEM: linkages 
and overlaps between 
settings with which the 
individual interacts 
MICROSYSTEM: the 
individuals direct 
interactions with their 
immediate surroundings  
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(microsystem).  Health system interventions which involved a combination of provider 
education and provider reminders were also seen as effective in supporting cessation.  
These represent external systems set up to remind the providers of the efforts being made 
to support smoking cessation (exosystem) and supported interactions between the smoker 
and the provider (mesosystem).   Policy changes that are implemented, such as raising the 
unit price of cigarettes and limiting the sites where tobacco is allowed, are also seen as 
effective interventions (macrosystem).   No studies were found using this type of a social 
ecology theory that report on programs designed to improve adherence to diabetes 
guidelines that have been implemented to the extent reported in this study.    
A social ecology perspective can also be seen as the theoretical foundation for the 
Chronic Care Model (CCM), the first formal system-level practice model reported in the 
literature designed to address the needs of individuals with chronic conditions.  The CCM 
acknowledges the importance of individual approaches to managing chronic illness such 
as self-management support but posits that effective management of chronic illnesses 
must include system level support and interventions (Wagner, Austin, &Vonkorff ,1996).  
The components of the CCM parallel the micro-, exo-, meso-, and macro-system levels of 
social ecology.   
A System Level Approach to Improving Adherence to Diabetes Guidelines:  
The Chronic Care Model 
The components of the CCM are designed to address the multifaceted approaches 
to behavioral changes that are addressed within social ecology theory. The CCM 
approaches the management of chronic conditions from an ecological perspective by 
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integrating system and organizational level factors in addition to individual level ones.  
An amalgamation of the best available information on effective management of chronic 
illnesses, the CCM addresses systems and the interrelations between different ecological 
levels of influence on health. Wagner, Austin, and Vonkorff (1996) reviewed available 
literature to help define factors related to effective management of chronic illness.  The 
Chronic Care Model (CCM) was developed based on the identified elements.  As shown 
in Figure 3, six elements were identified by Wagner, Austin and Vonkorff: a health care 
delivery system that is organized around support for chronic care management; links to 
community resources and partnerships between care systems and the local community; 
self-management support; delivery system re-design; advanced clinical information 
systems that provide feedback on performance; and, decision support for the providers of 
care (Wagner et al., 2001). The CCM practice model is designed to impact patient 
outcomes through productive interactions between an informed, engaged patient and a 
highly qualified practice team (Bonami, Wagner, Glasgow, & Von Korff, 2002).   
Some of the components of the model can be used to support individual-level 
interactions.  For example, advanced clinical information systems are used to trigger 
individuals to the program.  They are also used to provide feedback to the providers and 
the chronic care management staff as they work directly with the individuals to improve 
their knowledge and their adherence.  The significance of the model, however, is the 
system-wide interventions and support that reflect an organizational approach to address 
the problems of managing chronic illness. The following sections will more closely relate 
the CCM to Social Ecology Theory.  
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Figure 3. Elements of the Chronic Care Model  
Wagner E. H. Chronic disease management: What will it take to improve care for chronic 
illness? Effective Clinical Practice 1998; 1: 2-4 (Used with permission from the 
American College of Physicians). 
Ecological Theory and the Chronic Care Model 
The CCM can be understood in the context of social ecology theory.  The CCM 
acknowledges the need to use individual-level approaches, but proposes that widespread 
system-level intervention is the best way to have an impact on the behavior of individuals 
with chronic conditions.  Components of the CCM practice model address changes at 
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every level of the ecosystem delineated in the social ecology theoretical model. Table 2 
summarizes how the CCM links to Social Ecology Theory. This study tests social 
ecology theory in relation to impacting adherence to select guidelines in individuals with 
diabetes through the use of the CCM practice model.    
Microsystem 
The microsystem is the individual’s most immediate context and includes 
activities, roles and interpersonal relationships. This level involves relationships and 
interactions with family, friends, social support systems, work environment, and health 
professionals involved in the individuals life. The microsystem encompasses the person’s 
immediate contacts with whom face-to-face interactions occur; the situations and settings 
in which the interactions occur; and the direct or indirect influence these contacts and 
situations have on the individual (McLaren & Hawe, 2005). The CCM components 
related to microsystem influences on health behaviors are self-management support and 
linkages to community resources.   
Self-management support uses individual level interventions to improve self-
management and adherence to practice guidelines. Behavioral principles are applied in 
order to provide individuals with the knowledge and skills necessary to reach the desired 
outcomes (VonKorff, Gruman, Schaefer, Curry, & Wagner, 1997; Wagner et al., 2001).  
Effective self-management support involves providing education on the chronic condition 
and facilitating the individual’s ability to identify issues, identify resources and skills 
needed to address the issues identified, and to access the essential skills and resources 
(Epping-Jordan, Pruitt, Bengoa & Wagner, 2004).  Often case management personnel are  
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Table 2. Link between Social Ecology Theory and the Chronic Care Model 
Social Ecology Theory Level Chronic Care Model Components 
MicroSystem 
 
Interpersonal relationships 
Self-management Support – provided in the context 
of patient-provider relationship and by nurses 
educating the patient on their condition and self-
management skills 
 
Presence of community resources that interface with 
the patient 
MesoSystem 
 
Linkages between the different 
settings in which an individual 
directly interacts 
Advanced clinical information system which is used 
to link the patient, the treating provider and the nurse 
providing self-management support 
 
Non-physician support (nurses) who act as the link 
between the patient and the other members of the 
care system and community resources  
Exosystem 
 
The larger social system in 
which the individual resides 
but with which the individual 
may not directly interact 
Organization of health care away from acute care and 
towards chronic care management, including 
strategies throughout the organization focused on 
chronic care. 
 
Health system redesign which provides financial and 
policy support for the additional time required in the 
management of patients with chronic conditions  
 
Decision support which involves local physicians and 
other providers in the development and support of 
clinical guidelines   
 
employed to help provide this support with the goal of empowering individuals and 
facilitating effective interactions between the individual patient and the treating providers.   
The presence and availability of patient-oriented community support and 
resources is another micro-system level component of the CCM.  The resources available 
and accessed by patients provide opportunities for direct interaction with professionals 
and peers who help to sustain positive health-related behaviors.  Access to, and use of, 
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community resources such as exercise programs, hospital chronic disease programs and 
local support groups, has been shown to be an effective element of chronic illness 
management (Rothman & Wagner, 2003; Bodenheimer, 2003).   
Mesosystem 
 The mesosystem represents the linkages between the different settings in which 
an individual directly interacts.    The interconnectedness of the settings and structures in 
which the individual functions is seen as just as important as the individual’s 
interpersonal relationships in the support of an individual’s health (McLaren & Hawe, 
2005).   The CCM focuses on the link between the patient and the health system; the 
patient and the available community resources; and the patient and the physicians 
involved in their care.  There are two components of the CCM that facilitate the linkage 
between the microsystem settings or structures: advanced clinical information systems 
and the services of non-physician professionals.  
The information systems are used to link the payer, the different providers 
involved with the individual, and the providers of self-management support.    These 
advanced clinical information systems use administrative data from claims as well as data 
from electronic health records to identify individuals with the condition and to risk 
stratify individuals so that comprehensive approaches to address their needs can be 
applied.  In addition to the use of clinical information systems to identify patients and 
their needs these systems provide feedback to the treating physician on adherence 
behaviors (Bodenheimer, 2003; Rothman & Wagner, 2003; Rundall et al., 2002; 
VonKorff, Gruman, Schaefer, Curry, & Wagner, 1997; Wipf & Langner, 2006).   
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Non-physician professionals are also used as linkages between settings and thus a 
meso-system level of influence on a patient’s health.  These professionals, often case 
managers, bring skills in relation to providing direct self-management support but also 
coordination between the different settings with which the individual directly interacts.  
They are also available to the treating physician to support the treatment plan. 
Exosystem 
The exosystem is the level of influence that represents the larger social system in 
which the individual resides but with which the individual may not directly interact.  The 
systems and settings in this level interact with systems and settings in the individual’s 
microsystem.    Despite the fact that the individual does not directly interact with the 
settings in the exosystem, decisions are made in this system that directly impact the 
individual (Bronfenbrenner, 1979; Grzywacz, 2000; McLaren & Hawe, 2005).  The 
components of the CCM associated with the exosystem level are the organization of 
health care away from acute care management toward chronic care management; health 
system re-design; and decision support.  These supports provide a contextual framework 
for behavioral change and improved chronic care management at a exosystem level.   
The CCM views the support for chronic care management within the organization 
as an important addition to the individual level approaches to improving care of chronic 
illnesses.  The CCM posits that to effectively address health, health care organizations 
must be organized to support new approaches to chronic care. The model suggests that 
policies must be established that facilitate new approaches to care.  As mentioned in the 
discussion on the mesosystem level, relationships between providers and payers need to 
50 
 
be enhanced so that both support chronic care.  Support from senior leadership within the 
health system can provide support for this relationship.  Policies and payment structures 
can be enhanced to provide for the additional time required by providers to effectively 
manage chronic illnesses (Health Resources and Services Administration, 2006).   
Beyond organizational support is the redesign of the health delivery system to 
effectively enhance chronic illness care.  One example of this redesign and leadership 
support is change in the payment structure to physicians that provide reimbursement for 
the longer patient visits that are often required for individuals with chronic illnesses.  
Other health system redesigns involve the development of incentives to providers for 
quality chronic care management and the establishment of systems that facilitate 
coordination of care across organizations and settings (Bonami, Wagner, Glasgow, & 
Von Korff, 2002; Institute for Alternative Futures, 2006; Seaton, 2006).  
Another exosystem level of influence in this model is decision support.  This 
involves the engagement of clinical practitioners in establishing, selecting, or reviewing 
disease specific clinical guidelines.  It also involves making available to practitioners the 
clinical guidelines established or adopted by the organization (Epping-Jordan, Pruitt, 
Bengoa & Wagner, 2004).  Processes and financial support are needed that facilitate 
continuing education of providers in the advances and changes in chronic care 
management.  When clinical practitioners obtain continuing education on updated or 
newly developed clinical guidelines they become or remain current in evidence-based 
approaches to the management of chronic conditions (Rothman & Wagner, 2003; 
VonKorff, Gruman, Schaefer, Curry, & Wagner, 1997; Wagner et al., 2001a).  
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Macrosystem 
The macrosystem is the overall context in which the other ecosystem levels exist. 
Under the influence of the macrosystem, the individual interacts with levels of the 
ecosystem and interactions between other ecosystem levels occur.   McLaren & Hawe 
(2005, p. 11) define the macrosystem as “… the overall patterns of ideology and 
organisation that characterize a given society or social group, and may thus be used to 
describe the culture or social context of various societal groups …” It is within the 
context of the macrosystem that changes are made. The CCM approaches chronic care 
management from an organization level and does not necessarily address the larger 
community milieu that is represented by the macrosystem level.   Fisher, Brownson, 
O'Toole, Anwuri & Shetty (2007) have proposed an expansion of the CCM to include the 
wider community and systems that impact the health of individuals in the daily 
management of chronic conditions as well as the creation of policies that support chronic 
care.  The World Health Organization and the McColl Institute for Healthcare  
Innovations have joined to expand the CCM to the Innovative Care for Chronic 
Conditions framework.  Policy and wider community interventions are integrated into the 
framework to provide a more comprehensive milieu for chronic care management 
(Epping-Jordan, Pruitt, Bengoa & Wagner, 2004).  
Improved Adherence in the Chronic Care Model Approach 
Reports on programs implemented using the CCM practice model are beginning 
to emerge in the literature.  In 2006, Bodenheimer, Wagner, and Grumbach conducted a 
review of the research to date on the extent to which the chronic care model improved the 
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management of diabetes.  Thirty-nine studies were reviewed.  The authors examined 
which of the six components of the CCM were implemented.  Four or less of the 
components were implemented (self management support, decision support, delivery 
system design and clinical information systems).  The two that were not reported are the 
organizational changes and the integration of community resources. Based on the reviews 
they concluded that interventions based on the components of the CCM model were 
associated with some improvement in adherence behaviors.  Thirty-two of the 39 studies 
reviewed reported improvement in at least one adherence measure or one clinical 
measure.  At the same time the authors questioned the methodological quality of many of 
the studies and deduced that study interventions varied enough to make generalization 
difficult.   
Limited research has been conducted on the impact of the elements of the CCM 
on adherence for patients with diabetes.  Solberg et al. (2006) and Hroscikoski et al. 
(2006) reported on the results of implementing a program that incorporates the elements 
of the CCM into 17 primary care clinics.  The authors reported on the implementation of 
the CCM from a quantitative and qualitative perspective.  All six elements were in place 
at baseline and a 24% overall improvement was reported at the end of the study period. 
Changes in how the clinics implemented each of the six components were also measured.  
Delivery system design and self-management support improved the least and the 
improvement was not significant (p = .11 and .10 respectively).  No significant 
correlations between the CCM interventions and adherence behaviors were noted.    A 
review of two of the other research studies on implementing the CCM revealed that very 
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limited implementation of the components of the model occurred (Piatt et al., 2006; 
Siminerio, Piatt, & Zgibor, 2005).  Only one other program, implemented by the 
University of Pittsburgh and delineated below, reported on the overall support for wide-
spread policy and system level interventions.   
One program established by the University of Pittsburgh reported on the 
implementation of the CCM in an integrated delivery system serving over 15,000 patients 
(Siminerio, Zgibor & Solano, Jr., 2004; Siminerio, et al., 2006).  The program 
implemented all 6 elements of the CCM and focused on outcomes associated with 
improvement in self-management.  The program was implemented in 2000 and results 
were evaluated in 2003.  Provider practices were measured at baseline and at year three.  
The authors concluded that physician practices improved their patients A1C results from 
baseline.  No statistical significance was reported, however.  In addition to the reported 
improvement in A1C results by physician practice, adherence to an annual nephropathy 
screening was at 74% for the more than 4,000 patients who were tracked.  This was the 
only adherence result reported.  There was no comparison made either to pre-
implementation results or to a referent group and no statistical significance was reported.    
Both social ecology theory and the CCM point to the importance of overall 
system level interventions in impacting health-related behaviors.  Much of the research 
on the impact of the CCM takes the components of the CCM and tests only the impact of 
those components rather than the implementation of all components of the model.  For 
example in the research review conducted by Bodenheimer, Wagner, and Grumbach 
(2006) none of the 39 studies reported on the component of the CCM that represents the  
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overall organization of a health care system that supports chronic care management.  This 
approach ignores system level support for the management of chronic conditions.  Little 
is known of the impact of full implementation of the CCM on adherence to diabetes 
guidelines.  No studies to date have been conducted that compare adherence for 
individuals in programs that have implemented the full components of the CCM to those 
in groups that have not.   
This study views the CCM in the context of social ecology theory.  It is designed 
to test social ecology theory and the practice model for four areas of adherence to 
diabetes guidelines: HbA1c monitoring; lipid monitoring; nephropathy screening; and 
retinopathy screening.  Adherence to these guidelines are compared between patients 
whose health plan approached the management of diabetes by implementing only an 
individual level program and patients whose health plan has implemented a system-level 
program.  Figure 4 shows the relationship between the constructs of interest and the 
variables being studied.  
The hypotheses associated with these analyses are as follows: 
H1. There is no difference in adherence to lipid monitoring of individuals in a 
health plan that implemented a micro-, meso-, and exosystem approach to chronic care 
management compared to individuals in a health plan that implemented a microsystem 
approach alone. 
H2. There is no difference in adherence to retinopathy monitoring of individuals 
in a health plan that implemented a micro-, meso-, and exosystem approach to chronic  
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Figure 4. Conceptual Model  
care management compared to individuals in a health plan that implemented a 
microsystem approach alone. 
H3:  There is no difference in adherence to HbA1c monitoring of individuals in a 
health plan that implemented a micro-, meso-, and exosystem approach to chronic care 
management compared to individuals in a health plan that implemented a microsystem 
approach alone. 
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H4. There is no difference in adherence to nephropathy monitoring of individuals 
in a health plan that implemented a micro-, meso-, and exosystem approach to chronic 
care management compared to individuals in a health plan that implemented a 
microsystem approach alone. 
The research also examines the influence of the diabetes management approach, 
as well as individual level factors known to influence health-related behaviors, on 
improvement in adherence from pre program implementation to post program 
implementation.  The hypotheses associated with these analyses are as follows: 
H5: Approach to diabetes management is associated with a change in lipid 
monitoring adherence from pre-program implementation to post program implementation. 
H6: Approach to diabetes management is associated with a change in retinopathy 
monitoring adherence from pre-program implementation to post program implementation. 
H7: Approach to diabetes management is associated with a change in HbA1c 
adherence from pre-program implementation to post program implementation. 
H8: Approach to diabetes management is associated with a change in nephropathy 
monitoring adherence from pre-program implementation to post program implementation. 
Summary 
The management of patients with diabetes presents challenges that the health care 
industry continues to face.  Adherence is reportedly an important step towards improved 
clinical status and can be closely linked to interventions.  Because of the mediating role 
adherence plays, mediating between interventions and improved health, it is a variable 
that is important to focus on (Bodenheimer, Lorig, Holman & Grumbach, 2002; 
57 
 
Donabedian, 1985;  Jamner & Stokols, 2000; Kravitz & Melnikow, 2004; Patterson, 
2001; & World Health Organization, 2003, p. 23).   
Since the formalization of disease management programs almost 20 years ago, 
attention has been on programs designed to impact the health of individuals with diabetes.  
Many of these programs have been based on individual-level approaches and framed in 
individual-level theory, placing the focus on raising patients’ awareness of their disease, 
educating patients on the risks associated with poor disease management, increasing 
patient’s understanding of evidence-based guidelines, and enhancing patients’ self-
management skills.  Results of programs focusing on these individual-level interventions 
have been varied, leading to the development of other approaches to managing diabetes 
and other chronic conditions.   
Since the late 1990s increasing focus has been on system-level approaches which 
can be framed within a social ecology theory of behavior change.  Social ecology 
acknowledges the importance of the individual in behavior change thus integrating 
individual-level theories and approaches in the totality of a sociological approach.  Social 
ecology theory, however, points out that behavior change is multifaceted and 
interventions that impact behavior therefore must be multi-faceted.  As the health care 
industry has worked towards improvement in the management of diabetes a systems-level 
practice model has emerged.   
The Chronic Care Model incorporates interventions at the ecosystem levels of 
influence posited in the social ecology theory.  Research in relation to application of this 
practice model is in its infancy.  The complexity of diabetes and the persistent gaps in 
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care despite efforts at the individual level have lead to the application of system-level 
models to improve management of diabetes.  Chapter 3 presents the methodology used in 
this research to study the impact of these different approaches on adherence to diabetes 
screening guidelines.    
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CHAPTER 3: METHODOLOGY 
 
Purpose and Introduction 
This research explores the relationship between adherence to diabetes guidelines 
and approaches to diabetes management adopted by two employer-sponsored self-insured 
health plans.   It tests the effectiveness of applying social ecology theory, specifically the 
CCM practice model, to efforts to improve adherence to diabetes guidelines. The study is 
designed to determine whether there is a significant difference in select adherence 
behaviors between a health plan in which only individual level approaches have been 
implemented to address diabetes and a health plan in which system-level approaches as 
well as individual-level ones have been implemented.  In addition, the study examines the 
contribution of the approach to management of diabetes in relation to individual-level 
factors that are known to impact adherence. This chapter describes the research design, 
the variables of interest, the population being studied, the source of the data and the data 
analysis that is conducted.   
Research Design 
This study is a retrospective, descriptive, non-experimental study of a 
phenomenon that has occurred naturally as health plans have implemented programs to 
improve adherence behaviors and corresponding health outcomes for individuals who are 
covered under their plans.   The covered individuals are employees and dependents of 
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two hospitals located in Maryland, each having a unique health plan.   One of the health 
plans implemented a traditional chronic care program with an individual-level approach 
and one implemented a system-level effort to impact the health of their covered 
individuals with diabetes. The study involves a comparison of adherence to select 
guidelines for diabetes care in these two groups of patients for a two and a half year 
period post program implementation.  In addition it examines the relationship between 
the different approaches to diabetes management and change in adherence from two and 
a half years pre-program implementation to two and a half years post program 
implementation.  Figure 5 represents the design of this analysis with O1 representing 
multiple measures of compliance prior to the implementation of the diabetes programs, 
depending on the variable being assessed, and O2 representing multiple measures of 
compliance post implementation of the programs.  The comparison of the two approaches 
is assessed by evaluating differences between O2 for participants in the two health plans.  
Change in adherence behaviors are assessed by evaluating O2 minus O1 for each 
individual in each of the two health plans.  
 
                    Figure 5. Research Design  
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Data analysis is performed in three phases.  First, descriptive statistics are 
generated for the entire sample.  Second, a comparison between individuals in the health 
plan that implemented an individual-level approach to chronic condition management and 
individuals in the health plan that implemented a system-level approach are conducted.  
The comparison is designed to identify commonalities and differences between the 
groups on age, gender, number of hospitalizations since the program was implemented, 
number of co-morbid conditions, the presence of a consistent provider treating diabetes, 
and adherence to the guidelines for HbA1c, lipid, retinopathy and nephropathy 
monitoring.  T-tests are performed to compare the groups on age, the number of 
hospitalizations, the number of co-morbid conditions and the number of physicians 
treating diabetes. Chi-square analyses are conducted on gender and the categories of 
adherence. The third phase of the study identifies the impact of the approach to diabetes 
management on changes in adherence from pre- to post-program implementation in 
relation to individual level factors through a logistic regression model.  In this phase of 
the analysis, change in adherenceit = fx (age, gender, co-morbid conditions, the presence 
of a consistent medical provider and approach to chronic care management) where “it” 
equals individual change in adherence behavior over time. This analysis is conducted for 
each of the areas of adherence.    
Population of Interest and Sample 
The target population is individuals with diabetes. The accessible sample is 
individuals covered under the health plans associated with the two self-insured hospital 
employers in this study. The sample used to represent the population of interest is a 
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convenience sample.  All individuals covered under the health plans who meet select 
criteria are included in the study.  The criteria used to identify those eligible for the study 
are: they must have diabetes, as identified from the predictive modeling tool used by the 
Third Part Administrator (TPA); they must have been enrolled in the diabetes program; 
they must be 18 years or older throughout the study years; they must have been covered 
under the health plan for two and a half years prior to enrollment in the chronic care 
program and two and a half years after enrollment; and, the health plan must be the 
primary source of insurance.   The units of analysis for the study are individuals in self-
insured health plans.   Health plans are interested in improving the health of the covered 
individuals and mitigating their health-related costs.  Self-insured employers assume 
financial risk for the health benefits of their employees and dependents instead of paying 
an insurance carrier for coverage.  Individuals covered under self-insurance programs 
represent about 55% of all individuals under private insurance (Employee Benefit 
Research Institute, 2008).  Table 3 provides some information on the hospital employers 
whose health plans are the subject of this study including information on the health plans’ 
overall health care cost burden. This is represented in the per-employee-per-month 
(PEPM) cost. The PEPM is an average of the medical and pharmaceutical claims 
submitted over the past year per employee as of April 2008. 
Implementation of Diabetes Management Approach by Health Plans 
Both health plans implemented two components of the CCM: self-management 
support and clinical information systems. These components are associated with 
individual level approaches.  For both of the plans self-management support is provided  
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Table 3. Summary Data for Study Hospitals / Health Plans 
HOSPITAL # Employees 
Covered 
# Total Covered 
Lives 
PEPM  
Average cost 
A (Individual level) 1989 3998 $531 
B (System level) 2259 5046 $558 
 
through nurses identifying the needs of each individual triggered for the program and 
contacting them for education on the disease and support in the development of self-
management skills.  The same level and type of self-management support was provided 
for both health plans.  Although the self-management support was provided by different 
nurses, the nurses follow a standard process using specific guidelines for each of the 
areas of adherence of interest to this study. Samples of these guidelines are found in 
Appendix A.   
The same clinical information system was used by both health plans.  The clinical 
information system was used to identify individuals with diabetes who were then enrolled 
in the self-management program.  It was used to organize the claims information in a way 
that provided a picture of the needs of the individual.  The claims for both plans were 
used to measure adherence to diabetes practice standards.  This information was 
accessible to the nurses who worked with the patients to support self-management.  In 
addition, the plan that implemented the system-level approach used the clinical 
information system to provide feedback to the treating physicians.  A sample of this 
participant level claims information is found in Appendix B. 
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The other four components of the CCM were implemented by the health plan that 
provided system-level support for diabetes management.   The details of how these 
components were implemented are presented in Table 4. 
Identification of Sample 
Participants in the diabetes programs were identified by each plan through the use of a 
predictive modeling tool that has been assessed by the Society of Actuaries for predictive 
accuracy. Their assessment of the tool concluded that it is 86.4% accurate in its ability to 
predict those individuals who will have claims associated with a condition in the 
upcoming 12 months (Winkelman, Mehmud & Wachenheim, 2007).  The tool, Episode 
Risk Grouper (ERGs), developed by Ingenix, uses episodes of care (Episode Treatment 
Groups or ETGs) and demographic variables to provide an analysis of a population, as 
well as the identification of individuals with particular illnesses and level of risk.  ETGs 
were developed as an illness classification system with a methodology similar to 
Diagnosis Related Groups (DRGs), one of the most widely used illness classification 
systems.  The major limitation of DRGs is that they apply only to inpatient episodes.  
ETGs, however, utilize information from all encounters with health care providers 
obtained from claim or encounter form information from inpatient and ambulatory 
settings (including pharmacy).   
The tool builds “episodes” from this claim and encounter information, collecting 
all relevant utilization information and grouping it under one of 574 groups that have 
been determined to be statistically stable by the researchers at Ingenix (2006). The 
information used by the tool for grouping clinical events includes diagnosis codes (ICD9); 
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Table 4. Implementation of the Chronic Care Model Based on Social Ecology Levels 
 
Level CCM Plan A 
implementation 
Plan B Implementation 
MicroSystem Self-management 
Support  
Provided by nurses 
who are instructed to 
use the same 
guidelines for 
educating patients on 
their condition, the 
impact of poor 
management and self-
management skills 
Provided by nurses who are 
instructed to use the same 
guidelines for educating 
patients on their condition, the 
impact of poor management 
and self-management skills 
MicroSystem Linkages to / 
partnerships with 
community 
resources 
Not applicable  Organized relationship with 
Diabetes education program; 
behavioral health services; 
home health services.  
 
Once diabetes education is 
complete patient is "handed 
back" to the nurse who 
continues self-management 
support.  If additional 
education is needed the 
patient is re-referred to the 
diabetes education program 
for a refresher. 
MesoSystem Advanced clinical 
information system 
Not applicable for 
providing linkages 
across the settings 
directly involved with 
the patients. 
 
Used only to identify 
patients who have 
diabetes; risk stratifies 
patients and organizes 
claims information. 
Used to identify patients who 
have diabetes; risk stratifies 
patients and organizes claims 
information for the nurses 
providing self-management 
support. 
 
Used to provide feedback to 
the treating physicians - 
mailed to the physicians and 
/or physicians access on line. 
 
Community physicians, 
diabetes education center, 
medical director and nurses 
providing self-management 
support access the same 
clinical information system 
and current information 
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Table 4, continued 
 
Level CCM Plan A 
implementation 
Plan B Implementation 
MesoSystem Advanced clinical 
information system 
Not applicable for 
providing linkages 
across the settings 
directly involved with 
the patients. 
 
Used only to identify 
patients who have 
diabetes; risk stratifies 
patients and organizes 
claims information. 
Used to identify patients who 
have diabetes; risk stratifies 
patients and organizes claims 
information for the nurses 
providing self-management 
support. 
 
Used to provide feedback to 
the treating physicians - 
mailed to the physicians and 
/or physicians access on line. 
 
Community physicians, 
diabetes education center, 
medical director and nurses 
providing self-management 
support access the same 
clinical information system 
and current information 
MesoSystem Self-management 
support linking the 
patient with the 
resources / services - 
services of non-
physician 
professionals 
Not applicable for 
providing linkages 
across the settings 
directly involved with 
the patients. 
 
Nurses provide only 
individual support as 
patients’ needs are 
identified 
Nursing staff; team of 
physicians; medical director; 
diabetes education, behavioral 
health and home health 
professionals; executive team; 
meet to develop plans for 
individuals and outreach to 
community physicians 
 
Community physicians are 
notified of the program and 
the availability of nursing 
professionals to support the 
treatment plan.  
 
Weekly meetings by 
interdisciplinary team (care 
coordination team) to assure 
that patients have easy access 
to community resources. 
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Table 4, continued 
 
Level CCM Plan A 
implementation 
Plan B Implementation 
Exosystem Organization of 
health care away 
from acute care and 
towards chronic care 
management 
Not applicable Support throughout the 
organization.   Strategic 
engagement in improving 
chronic care. Initiative 
adopted by hospital 
executives; health plan 
administrator and key 
community physicians.  
Improving chronic care illness 
care and coordinating between 
the hospital and the 
community physicians is set 
as an organizational initiative. 
Exosystem Health system 
redesign 
Not applicable Involves community 
physicians in design of 
feedback report.  Engages 
with community physicians in 
developing plans to allow 
additional visit time for 
individuals with chronic care 
as well as time to review the 
feedback from the clinical 
information system 
Exosystem Decisions support Not applicable Hospital and community 
physicians collaborate to 
review and adopt clinical 
guidelines used to support 
patients with diabetes. 
Endocrinology, podiatry and 
ophthalmology specialists 
accessed to lead the review of 
clinical guidelines.  Care 
coordination team meets with 
community physicians to 
educate them on the 
guidelines and the use of the 
clinical information system. 
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procedure codes (CPT and HCPC); pharmacy information (NDC); the specialty of the 
providers (if known); and the place of service. As these data come into the claims system 
the ETG grouper evaluates the information with respect to each other and in relation to 
criteria tables.  The claims data are grouped with a specific ETG and continue to be 
grouped as long as the illness is being treated. The ETGs then become the building blocks 
of the ERGs (Symmetry, 2006). Both of the plans use the ERG tool routinely to identify 
individuals for chronic care programs.  
For the diabetes programs implemented by the plans, individuals who were 
predicted to have diabetes-related claims in the next 12 months were chosen for 
enrollment. This same tool was used to identify subjects for this study. Initially there 
were a total of 468 individuals identified as having diabetes in the plan providing the 
individual-level approach only (plan A).  There were 483 individuals identified as having 
diabetes in the plan providing not only an individual-level approach but also a system-
level approach (plan B).  These individuals had been identified by each plan for 
enrollment in the diabetes management programs.  Individuals were removed from this 
list for this study based on the following criteria: There was no indication of enrollment 
in the diabetes program or enrollment in the program occurred before the age of 18.  In 
addition, claims data had to be available two and a half years pre-enrollment in the 
program and two and a half years post-enrollment in the program.  Once the individuals 
not meeting all criteria were removed the total number of study subjects in plan A 
(individual) was 150 individuals and plan B (system) 174 individuals.    
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Sample size for testing the hypotheses was assessed.  A power analysis was 
conducted using general guidelines. Three pieces of information are needed to determine 
the sample size: a significance criterion, a power and an effect size.  A significance 
criterion of .05 and a power of .80 were selected. These are conventional standards for 
the research in this phase of the study (Polit & Hungler, 1999).  Since there is no previous 
research providing information on effect size, estimates of expected effect size were 
made.  The effect size provides an indication of the strength of the effect of the 
independent variable on the dependent variable.  Sample sizes using the following effect 
sizes are: a.) 0.30 requires a sample of 174; b.) 0.40 requires a sample of 98; and c.) 0.50 
requires a sample size of 63.  The sample size used in this study is adequate for the 
different effect sizes that represent a moderate effect (Polit & Hungler; p 492).  Although 
the sample size is adequate, the sample is a convenience one. Therefore, caution is taken 
in interpreting the results.  
Neither racial nor socioeconomic information are available as demographic data 
are obtained from files obtained when the employee enrolls in the health plan.  Racial and 
socioeconomic questions are not routinely captured in this administrative data.   All 
individuals in this study are either employed or a dependent of an employee and all 
individuals have private health insurance only. No participants with Medicare, Medicaid 
or other insurance were included in the study because the receipt of services through 
Medicare, Medicaid or other insurance would not be captured in the administrative data.    
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Data 
For this study the data for both the independent and dependent variables are 
secondary data, obtained from enrollment and claims files.  These are categorized as 
administrative data.  Administrative data are described as data that are collected for 
purposes other than those specified for research.  The purpose for the data collection is 
usually for reimbursement or billing.  They may be obtained from a variety of sources 
often from federal and state governments and private health insurers.  Data are 
aggregated by diagnosis codes and procedure codes (Iezzoni, 1997a; Iezzoni, 1997b).  
Administrative data have limitations but can be useful in initially assessing a topic of 
interest. The usefulness of administrative data in research has been acknowledged by the 
Advisory Panel on Research Uses of Administrative Data of the Northwestern University 
/ University of Chicago Joint Center for Poverty Research (Hotz, Goerge, Balzekas & 
Margolin, 1998).  The usefulness of administrative data has also been recognized by the 
Agency for Healthcare Research and Quality (AHRQ).  The problems associated with 
inaccurate data can be minimized through a process of analysis of the quality and 
validation of the information (Billings, 2007).    Despite the drawbacks associated with 
administrative data, Iezzoni (2002) stressed the benefits of using administrative databases 
particularly for measurements of payment, costs and patterns of service utilization.  
Enrollment data are gathered by each of the self-insured plans at the time of 
enrollment in the plan and are maintained over time.  Enrollment data provide 
information on gender and age.  They also provide information on date of enrollment in 
the plan and termination from the plan. This information was used to identify subjects for 
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the study and to describe the subjects enrolled in the diabetes programs.  Claims data are 
gathered only when claims are made and are used in this analysis to determine adherence 
to diabetes guidelines; the involvement of a consistent treating physician; the number of 
hospitalizations; and the number of co-morbid conditions.  Claims information for each 
of these plans is used for payment, but it is also used to predict risk and to develop a 
clinical profile that is encounter-based. In this analysis it is used to measure adherence to 
evidence-based guidelines. Adherence to guidelines is a measure of interest to the plans 
since improvement in adherence is seen as an indication of program success and is linked 
to positive clinical status.  Procedure codes from the administrative data are used to 
measure adherence to the recommended guidelines for management of diabetes.  Table 5 
provides a summary of the data sources used for this study.  
Data Organization 
Independent Variables 
The primary independent variable for testing of the four hypotheses is the 
approach to diabetes management used by the health plans that are the subject of this 
study.  Each plan implemented their chronic care management program and enrolled 
participants in the program over a period of 10 to 12 months.  Adherence results are 
examined for each participant based on their date of enrollment.  An initial assessment of 
the difference in adherence between patients receiving the different approaches is 
conducted using adherence data for two and a half years after the implementation of the 
chronic care program.  This analysis helps to answer the research question: Is there a 
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Table 5. Variables with Corresponding Data Sources 
Variables and Source of Data 
 
Independent Variables 
Variable  Source 
Approach to chronic care management Plan description – System versus Individual 
Age Administrative data – enrollment 
Gender Administrative data – enrollment 
Co-morbid chronic conditions Administrative data – claims 
Hospitalizations post implementation Administrative data – claims 
Consistent clinical provider Administrative data – claims 
 
Dependent Variables 
Adherence to diabetes care: HgbA1c, 
lipid, nephropathy and retinopathy 
screening 
Administrative data – claims 
 
difference in adherence behaviors of individuals in a health plan that implemented a 
system level program and those in a health plan that implemented an individual level 
program only?  The system-level program is the one in which all components of the 
CCM were implemented to provide support for chronic illness care.  The implementation 
of these components is an indication of a full system level approach to the management 
of chronic illnesses.  The individual-level group is the one in which only an individual 
level approach was implemented with no system level approach.  
Other variables of interest are included into the regression analysis.  These 
variables are age, gender and the following.  The significance of these factors in relation 
to management of chronic conditions was discussed in detail in Chapter 2 and the factors 
are summarized here:  
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• Co-morbid chronic conditions.  Co-morbid conditions may impact the patient’s 
perception of risk thus impacting behavior change.  According to individual level 
theories, individual perceptions of risk are often associated with changes in 
health-related behaviors.  The Health Belief Model (Glanz, Lewis & Rimer, 1997), 
the Transtheoretical Theory (Prochaska & DiClemente, 1983) and the Theory of 
Planned Behavior (Ajzen, 2002; Glanz, Lewis & Rimer, 1997) all indicate that an 
increased awareness of the consequences of inaction may lead to behavior change.  
• Hospitalizations post implementation of the program.  As with the presence of co-
morbid conditions, hospitalizations may impact the patient’s sense of urgency to 
change health-related behavior. Since diabetes impacts many body systems, the 
hospitalizations are not limited to hospitalizations for a diabetes diagnosis.  
• Evidence of a consistent clinical provider in the management of diabetes.  
Research indicates that a well established relationship with a treating physician 
can impact the adoption of healthy behaviors (Ciechanowski, et al., 2004; 
Maddigan, Majumdar & Johnson, 2005; Rothman & Wagner, 2003).  The number 
of physicians is a proxy for patient-physician relationship, with the assumption 
that the more physicians treating diabetes, the less likely the relationship between 
patient and physician is consistent and productive. 
The addition of these variables in the logistic regression model are used to answer the 
research question:  Can adherence to selected evidence-based guidelines be predicted by 
age, gender, co-morbid conditions, number of hospitalizations, evidence of a consistent  
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medical provider, and approach to diabetes management (system-level or, using SET 
categories, micro-meso-exo level versus individual-level only or micro level only)?   
Dependent Variable 
The dependent variable in this study is adherence to four diabetes management 
guidelines, specifically adherence to the recommended frequency for the following:   
hemoglobin A1c monitoring (two times per year), cholesterol monitoring (yearly), 
retinopathy screening (yearly) and nephropathy screening (yearly).  CPT and HCPC 
codes are used to identify receipt of these services.  Table 6 shows the codes that are used 
and the corresponding categories of adherence for each of the variables of interest.  
Receipt of a service with one of these codes counts as adherence for this analysis.   
Adherence is a multidimensional concept and is reportedly challenging to 
measure.  There are also no accepted guidelines for measuring adherence (World Health 
Organization, 2003 & Mihalko, et al., 2004).  Recommendations for frequency of these 
services are yearly (lipid levels, retinopathy and nephropathy screenings) or at least twice 
a year (HgbA1c).  Changes in adherence are measured by determining the pattern of 
adherence prior to enrollment in the program in comparison with post enrollment.  The 
results are categorized as follows. If frequency of receipt of the service increased post 
implementation the result is designated as improvement in adherence. If there is no 
change in receipt of the service post implementation and gaps in recommended frequency 
exist or frequency of receipt of the service decreased post implementation the results are 
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Table 6: CPT / HCPC Codes for Recommended Screenings for Diabetes Management 
Exams - CPT / HCPCs 
Retinopathy Screening – CPT / HCPCs 
2022
F 
Dilated retinal exam 
w/ interpretation 
67208 Dilated Eye 
Exam 
92230 Ophthamological 
visit 
3072
F 
Eye exam – low risk 
for retinopathy 
67210 Dilated Eye 
Exam 
92235 Ophthalmological 
visit 
67101 Dilated Eye Exam 67218 Dilated Eye 
Exam 
92240 Ophthalmological 
visit 
67105 Dilated Eye Exam 67227 Dilated Eye 
Exam 
92250 Ophthalmological 
visit 
67107 Dilated Eye Exam 67228 Dilated Eye 
Exam 
92287 Ophthalmological 
visit 
67108 Dilated Eye Exam 92002 – 
92014 
Ophthalmolog
ical visit 
99172 Ophthalmological 
visit 
67110 Dilated Eye Exam 92015 Ophthalmolog
ical visit 
99173 Ophthalmological 
visit 
Exams - CPT / HCPCs 
67112 Dilated Eye Exam 92018 – 
92019 
Ophthalmolog
ical visit 
S062
0 
Ophthalmological 
visit 
67141 Dilated Eye Exam 92225 Ophthalmolog
ical visit 
S062
1 
Ophthalmological 
visit 
67145 Dilated Eye Exam 92226 Ophthalmolog
ical visit 
S062
5 
Ophthalmological 
visit 
Hemoglobin A1c – CPT 
83036 Glycosolated Hemoglobin 
(A1C) 
83037 Glycosolated Hemoglobin 
by a device approved for 
home use 
Lipid – CPT / HCPCs 
80061 Lipid Panel 83704 Lipid Testing 83718 Lipoprotein 
83700 Lipid Testing 83715 Lipoprotein 83721 Lipoprotein 
83701 Lipid Testing 83716 Lipoprotein 84478 Triglycerides 
        3011
F 
Lipid Panel results 
documented and 
reviewed 
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Table 6, continued 
Nephropathy – CPT / HCPCs 
82042 Albumin – 
urine or other 
sources 
82044 Microalbumin, 
Semi-quant 
3060
F 
Positive 
Microalbumin test 
result documented 
and reviewed 
82043 Microalbumin, 
Quantitative 
3062F Positive 
macroalbumin 
test result 
documented and 
reviewed 
3061
F 
Positive 
Microalbumin test 
result documented 
and reviewed 
 
designated as no improvement in adherence. If there is no change in receipt of the 
services and no gaps in recommended care exists pre and post program implementation 
the result was removed from the analysis. Since the required frequency for the diabetes 
screenings is every six months (HgbA1c) and yearly (lipid, nephropathy and retinopathy 
screening) and since the data available covers only two and a half years post 
implementation the limited time frame makes it difficult to link the approach with 
sustained changes in adherence. However, initial changes in the behaviors of interest for 
this study are seen as steps towards adherence.  They represent awareness of the behavior 
and initial engagement in the behavior.  Maintenance of the behavior is not measured at 
this time because of the short range of time for the study. The concept of adherence for 
the purposes of this analysis is depicted in Figure 6, where the nurses who provide self-
management support raise the participants’ awareness of the required behavior and the 
performance of the behavior by the patient is measured through claims.  
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Figure 6. Adherence Behavior: Awareness Measure 
 
The variables of interest represent both individual-level and system-level factors 
that influence adherence. Table 7 presents all independent variables in this analysis.  It 
also provides information on the type or level of each variable and a summary of how 
each variable is measured.   
Table 7: Study Variables: Independent 
VARIABLES 
Independent Variables 
Variable  Measure Type / Level 
Approach to chronic care 
management 
0=Individual      1=System Nominal  
Age Years Continuous 
Gender M / F Nominal / 
Dichotomous 
Co-morbid chronic conditions Number of conditions Continuous 
Hospitalizations post 
implementation 
Number of hospitalizations Continuous 
Consistent clinical provider Number of providers managing 
diabetes 
Nominal 
 
Table 8 presents information on the dependent variables for both phases of the 
study. Information on the level of the variable is also presented. In addition, the table 
presents specific information on how change in adherence is determined. 
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Table 8. Study Variables: Dependent 
Dependent Variables 
Variable  Measure Type / Level 
Adherence to diabetes care 
post-program 
implementation: HgbA1c, 
lipid, nephropathy and 
retinopathy screening 
 
For comparison of the 
subjects receiving the 
different approaches 
Yes / No Nominal 
Changes in adherence to 
diabetes care: HgbA1c, 
lipid, nephropathy and 
retinopathy screening 
 
For regression analysis 
Change in adherence behaviors is 
represented in the research model as 02 – 
01 for each individual with 02 
representing adherence behavior patterns 
two and a half years after implementation 
of the program and 01 representing 
adherence behavior patterns two and a 
half years prior to program 
implementation. 
 
Results: 
No change in adherence behaviors if gaps 
in required screenings are present or 
adherence behaviors in relation to 
guideline frequency for screenings is less 
two and a half years post as compared to 
two and a half years prior to program 
implementation – assigned 0 
 
Adherence behaviors in relation to 
guideline frequency for screenings is 
more two and a half years post as 
compared to two and a half years prior to 
program implementation – assigned 1 
Nominal 
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Data Analysis 
Raw claims data in a de-identified form are supplied by the TPA to the researcher.  
Permission has been obtained from both of the plans for access to their de-identified 
administrative and claims data for the purpose of this analysis.  The TPA has approved 
the use of the data for this research and a HIPPA disclosure has been signed. According 
to the VCU Office of Research Compliance and Education, this research is not 
considered human investigation and therefore does not require IRB review.  The 
following criteria have been met that qualifies the research for IRB review exemption: 
the coded, private information was not collected specifically for the research being 
conducted and the researcher can not readily ascertain the identity of the individuals to 
whom the information pertains.  An attestation signed by the representative from the 
TPA, the dissertation chairperson and the student investigator confirms agreement to 
these criteria.   
This study involves a retrospective analysis of the administrative data from claims 
and enrollment.  Enrollment and claims data provide information used in the descriptive 
statistics.  Information on age, gender, date of enrollment in the plan and date coverage is 
terminated (if applicable) is available in the enrollment data. Claims data include the 
number of hospitalizations, other chronic conditions and the presence of a consistent 
clinical provider.  Individuals are designated as receiving micro-level approach only and 
micro-, meso-, exo-level approach. T-tests for independent samples are conducted for age, 
number of hospitalizations, number of co-morbid chronic conditions and number of 
physicians treating diabetes.  Chi-square tests are conducted for gender and adherence to 
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each of the four guidelines of interest.  The comparison between the two approaches on 
adherence post-program implementation helps to answer the research question: Is there a 
difference in adherence behaviors of individuals in a health plan that implemented a 
system level program and those in a health plan that implemented an individual level 
program only? 
Descriptive statistics are completed on the entire sample and comparisons are 
completed on patients receiving the different approaches to diabetes management. Once 
this is complete the impact of the approach on adherence changes from pre-program 
implementation to post program implementation is assessed through logistic regression.   
Logistic regression analysis is used to predict a dichotomous categorical variable from 
multiple predictive variables (Leech, Barrett, & Morgan, 2005). Variables that are being 
assessed for their predictive relationship to change in adherence are entered into the 
model.  The odds ratio (Exp β) for each independent variable is assessed to determine the 
predictive relationship between the dependent variables and changes in adherence. The 
correlation coefficient (R squared) is assessed to determine the strength of the model, 
with all variables, in relation to change in adherence. These analyses help to answer the 
research question: Can adherence to selected evidence-based guidelines be predicted by 
age, gender, co-morbid conditions, number of hospitalizations, evidence of a consistent 
medical provider, and approach to diabetes management (system-level versus individual-
level only)?  The analysis for each dependent variable is performed in the same way 
(HgbA1c; lipid levels, nephropathy and retinopathy screening).  Results are presented in 
the next chapter. 
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Limitations 
Measurement Quality 
Measurement quality involves the validity and reliability of the variables chosen 
and the tools used to determine the results.  In relation to measurement validity, face, 
construct and criterion-related validity are considered.  These address how the variables 
are operationalized.  The dependent variables selected for this study have face and 
construct validity since they represent the construct of adherence to diabetes guidelines.  
Some of the major complications of diabetes are blindness, kidney disease and heart 
disease.  To control the progression towards these complications the American Diabetes 
Association (ADA) and the Centers for Disease Control (CDC) recommend control of 
both glucose and lipid levels.  Proper control is monitored though the regular testing of 
HgbA1c and lipids.  To help control the progression towards kidney disease and 
blindness both the ADA and the CDC recommend regular screening for nephropathy and 
retinopathy through tests for Microalbumin and eye exams (American Diabetes 
Association, n.d.; Centers for Disease Control, 2007).   
Measurement reliability relates to the consistency of the measurement.  Test / re-
test and Cronbach’s Alpha are used to test the reliability of measures. A test / re-test is 
conducted and a test for correlation of results is completed. Since these are administrative 
data collected for other reasons than for research test / re-test is not possible in this study.  
Cronbach’s Alpha test for internal consistency takes the set of measures and splits them 
in different ways to test the correlation between them and the sum of related items.  The 
data used in this study provide information on dates selected tests were received.  From 
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this date information, conclusions regarding changes in adherence are being made.  The 
conclusions are nominal.  Therefore a Cronbach’s alpha analysis is not a possible test for 
reliability.    
However, measurement quality is assessed through an analysis of the strengths 
and weaknesses of the administrative data.  Some of the strengths are that this data 
provide utilization information across all service providers and the utilization patterns can 
be linked to the individuals covered by the specific plans of interest to this study. There 
are several approaches that can be taken to obtain utilization information.  One method is  
chart review.  This would involve obtaining access to charts for identified individuals and 
obtaining agreement from all participants and their service providers. It is also costly to 
perform. The second method is self-report from patients regarding the services they have 
received.  Again, individuals would have to be identified and surveyed and patient recall 
is not always exact.  The third method is the use of administrative data.   
The accuracy of administrative data has been compared to the accuracy of self-
report in relation to the ability to identify risks and measure performance against standard 
guidelines (Fan, Maciejewski, Liu, McDowell & Fihn, 2006; Thompson, et al., 2001; 
Vojta, et al., 2001).  In Fan, et al. (2006), administrative data was reported to be at least 
as accurate as self-reported data and at times substantially more accurate.  Thompson et 
al. (2001) concluded that administrative data provide more accurate information 
particularly when the information desired is related to utilization patterns and procedure 
codes.   
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The accuracy of administrative data has also been compared to a review of 
medical records.  Diamond, Rask & Kohler (2001) conducted a study that assessed 
outpatient performance indicators through administrative data and review of medical 
records. The report indicated that administrative data identified more patients who 
received select screenings.  One of the outpatient services that were evaluated was 
specific to the receipt of retinopathy screening for patients with diabetes.  The authors 
concluded that administrative data captured a greater proportion of patients who received 
retinopathy screenings (44% versus 27%, p< 0.001). They pointed out that the lack of 
standardization of medical record documentation can lead to limitations in identifying the 
receipt of services.   
The limitations of administrative data have also been reported in the literature, 
particularly in relation to the ability of the data to reflect clinical quality and the accuracy 
of the coding (Iezzoni, 1997).  The main weakness of this administrative data is that there 
are no tests of its reliability, although the quality of the data is checked through the 
process performed by the Third party Administrator (TPA).  Evidence of the quality 
report card generated by the TPA is included in Appendix C.  The report card is 
generated through the quality process performed when claims and enrollment data are 
received.  Once collected by the plan, the data are imported into one central database 
maintained by a common TPA, used by both of the represented health plans.  The TPA 
provides the plan with a data layout that identifies the fields that are necessary for a 
complete file.  Once the data are imported, a report card is generated and reviewed by the 
plan.  Errors are addressed until they are resolved.  Quality assurance reviews are 
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performed to assure that the data are complete and accurate.   Once the process is 
completed, an automated process is performed that updates the files on a monthly basis. 
Report cards are generated on a monthly basis, as well and reviewed by the TPA and the 
health plan.   
Design Quality 
Threats to research design quality fall into several categories.  External validity 
refers to the ability of the research to be generalizable.  Generalizability is related to the 
ability to say that the research was designed in such a way that the results can be 
applicable to other situations and other populations. The sample may not be 
representative of the entire diabetic population. The individuals being studied in this 
research are covered under self-insured health plans.  While a high percentage of 
privately insured individuals are covered under self-insured plans, 27% of all individuals 
are covered under government insurance and 15.8% of individual are uninsured 
(DeNavas-Walt, Proctor & Smith, 2007).  Because they are not represented in the study 
results are not generalizable to these coverage types.  The employers are both hospital 
systems.  The employees, their dependents and the providers are located in a single state.  
These factors also limit the generalizability of the study. 
Internal validity of research design refers to the ability of the research to support 
the claim that the intervention is linked to the outcome.  History is one specific threat that 
falls into this category.  History threats can occur when external factors impact the results 
rather than the intervention itself.  This research examines changes in adherence to 
diabetic screenings and monitoring over a two and a half year period.  Other factors may 
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have played a role in the results.  Increased awareness of the importance of diabetes 
management may have occurred, such as local media reports of healthy behaviors related 
to diabetes.  Maturation is another threat to the internal validity of the research.  
Maturation is the effect of time on the changes being studied.  For this research, the 
patients have naturally matured over the five years of the study.  The program itself may 
have matured and changed over the period of time as well.  Assurances have been made, 
however, that no substantive changes in the program occurred during the two and a half 
years after the programs were implemented through interviews with leaders in each of the 
health plans. However, as physicians have become more aware of the initiatives to 
improve diabetes management their involvement in making the initiative a success may 
have impacted the overall program.  
Selection of subjects refers to a bias that may occur as a result of selection of the 
subjects.  Selection of the subjects was completed on a convenience basis and included 
patients who had continuous coverage with the plans for at least four years.  There may 
be a quality in the individuals that remain with stable employment and stable insurance 
coverage that influences the intermediate outcome of adherence. While these threats are 
acknowledged as possible in this research, the statistical control employed in the 
comparative analysis help mitigate some of the risks associated with these threats.  
Caution must be used in interpretation and discussion of the results. 
Statistical conclusion validity is related to biases that may occur as a result of an 
improper use of statistics including a low reliability of measures and reliability of 
treatment implementation. The low reliability of measures may be seen in the selection of 
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the screenings.  The screenings that were selected for this study are required annually 
(lipid, nephropathy and retinopathy screening) or every six months (A1c).  Adherence 
measurements for the study span a two and a half year period prior to implementation of 
the chronic care program and two and a half years after implementation.  The short time 
span of the study may represent a threat to conclusion validity. Statistical conclusion 
validity can be strengthened through a research design with adequate power (at least .80) 
which this research has attempted to address. However, an issue with sample size has 
been identified that may lead to a type 2 error and an overestimation of the odds ratio. 
The issue is related to sample size.  Although overall sample size is adequate, the sample 
size for three of the logistic regression analyses is lower than desired.  
Multiple factors impact adherence behaviors, including health perceptions; 
individual characteristics such as coping styles; social circumstances such as supportive 
resources; knowledge; motivation and past success in improving health behaviors; the 
quality of the patient-provider relationship; ease of access to providers and services; 
treatment; and, disease characteristics (Sherbourne, Hays, Ordway, DiMatteo and Kravitz, 
1992; World Health Organization, 2003).  Controlling for all of these factors was not 
possible as measures were not available in the administrative data. However, some of 
these factors are considered in this research.  The research factors included in this 
research are: individual characteristics such as age and gender; the patient-provider 
relationship as measured by the patient consistently receiving services from one provider; 
and disease characteristics as measured by the presence of co-morbid conditions and 
frequency of hospital admissions.  
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A threat to reliability of treatment implementation may be evident in the fact that 
different nurses interact with the patients to provide self-management support.  The 
different personalities may impact the outcome as opposed to the system-level approach 
implemented.  The tools and processes used by the plans, however, may help to mitigate 
this threat.  The nurses who educate the patients on the guidelines undergo the same 
training.  They also use the same tool that contains the diabetic guidelines and 
instructions on how to help the participant improve adherence behaviors.   
Threats to construct validity occur when there are not clear operational 
definitions.  Adherence is a complex term. For this study adherence is defined as the 
extent to which a person’s behavior is consistent with recommendations from health 
providers.  Using claims data for analysis of screening and monitoring completed 
standardizes the measurement for all participants. Sustained changes in adherence are not 
measured by this research since there are only two and a half years of data post 
implementation of the program.  However, initial changes in behavior are seen as 
evidence of awareness and beginning adoption of the behavior, the steps towards 
sustained adherence (Johnson, 2002; Pathman, Konrad, Freed, Freeman & Koch, 1996).  
The changes in adherence behavior are consistent with recommendations in national 
guidelines and are the focus of this analysis.  Table 9 provides a brief summary of the 
threats to research quality identified in this study. 
Summary 
This chapter presents the methodology used in this research.  This retrospective, 
non-experimental study examines changes in adherence to diabetes guidelines based on  
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Table 9. Summary of Threats to Research Quality 
THREAT / 
LIMITATION 
  
Design Quality Description 
Generalizability Study group is fully insured and employed by a self-insured 
employer.  Results may not be generalizable to other 
coverage types and the uninsured. 
History Study period covers a five year span of time.  Other factors 
may have occurred over that span of time that influence the 
results. 
Maturation Both the patients and the programs may have matured over 
the five year period in such a way as to influence to results. 
Selection of Subjects A convenience sample and the inclusion criteria may lead to 
a non-representative sample.  The sample consists of patients 
who had continuous coverage with the employer for five 
years.  There may be characteristics of these employees that 
influence adherence. 
Statistical Conclusion 
Validity 
Possible low reliability of measures due to the frequency of 
monitoring required in relation to the time span of the study 
Measurement Quality Description 
Reliability of 
Treatment 
Implementation 
Different nurses delivered the information to the patients 
regarding the required screenings.  A script, however, was 
used by all the nurses for both plans. 
Construct Validity Adherence is a complex and multifaceted construct making it 
difficult to control for all factors that contribute to adherence 
Construct Validity How variables are operationalized - Variables selected are 
accepted as measurements of adherence to diabetes 
guidelines 
Reliability   Administrative data - no tests of reliability are possible.  TPA 
process for assuring accuracy and quality of the data will be 
reported 
 
health plan implementation of a system-level approach. Administrative data are used to 
assess adherence to HgbA1c, lipid monitoring, retinopathy screening and nephropathy 
monitoring.  Descriptive analyses are conducted.  Comparison of adherence between 
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patients covered by plans that had implemented an individual-level approach only versus 
the one in plans in which a systems-level approach has been implemented is conducted.   
Finally, for all individuals in this study an analysis of factors that are most predictive of 
improvement in adherence is conducted 
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CHAPTER 4: RESULTS 
 
This research explores the relationship between adherence to diabetes guidelines 
and approaches to diabetes management adopted by two employer-sponsored self-insured 
health plans.   Framed in social ecology theory, this study explores the effectiveness of 
using the CCM practice model on efforts to improve adherence to diabetes guidelines. 
The study is designed to determine whether there is a significant difference in select 
diabetes adherence behaviors between a health plan in which only individual level 
approaches have been implemented (micro only) and a health plan in which system-level 
approaches, as well as individual-level ones, have been implemented to improve the 
health of individuals with diabetes (micro- meso - exo).  In addition, the study examines 
the contribution of the approach to management of diabetes in relation to individual-level 
factors that are known to impact adherence.  
This chapter presents the results of this study. It begins with descriptive 
information about all the subjects in the study and the differences between the two 
populations enrolled in programs providing chronic care through the different approaches.  
An analysis of the differences between the two groups on adherence after implementing 
the diabetes programs is also presented.  The chapter then focuses on the results of the 
regression analysis, analyzing adherence while controlling for individual factors that 
affect it.  
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Health Plans 
The focus of this study is the approach to diabetes management adopted by two 
health plans.  The approach is framed in social ecology theory.  Both health plans are 
self-insured hospitals.  Both implemented an individual level approach, micro-system in 
social ecology theory, in which the same information system was used to identify patients 
with diabetes.  In addition to patient identification, the information system used claims 
and enrollment data to provide a clinical picture of the needs of each participant. This 
information was used by the nurses who provided self-management support.  Both 
systems employed nurses who outreached to the identified patients and educated them on 
the management of diabetes.  The same patient management system and guidelines were 
used by the nurses who outreached to the patients from both health plans.  One health 
plan’s program implemented these individual-level interventions only.  The second health 
plan implemented system level changes in addition to the individual level approach. This 
health plan began their efforts to improve diabetes management by establishing 
organizational support for the initiative. The initiative was adopted by top executives of 
the organization. The health plan engaged with community organizations to establish a 
support system for participants in the program. The plan also engaged with community 
physicians, eliciting their help in supporting the guidelines and processes. The 
information system used by the nurses was also used by the community physicians to 
provide feedback on the patient's progress. A care coordination team, made up of 
members from multiple disciplines, met on a regular basis to provide ongoing support for 
the chronic care program. These features of the program enhanced the micro level 
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approach implemented by both health plans by adding meso- and exo-system level 
support.  
Subjects 
The subjects, whose adherence to diabetes guidelines are analyzed in this research, 
are individuals with diabetes who are members of the two health plans. A total of 951 
individuals were identified through the claims data of the two plans as having claims 
associated with diabetes.  Of the individuals identified (n=951), patients were initially 
excluded from the study (n=531) for the following reasons: other insurance as primary 
thus limiting access to claims to be used for the analysis; not enrolled in the plan for a 
long enough period of time for the analysis to be accurate (two and one-half years prior to 
and post program implementation); and under the age of 18 at the time of the initial 
measurement.  Once this sample was selected, further review of the data was conducted 
and missing fields were identified.  According to Polit & Hungler (1999) there are five 
ways of dealing with missing or incorrect variables: deletion of the cases where data are 
missing; deletion of the variables; substituting the mean value; estimating the missing 
value; and, deleting cases selectively and pairwise.  All of these were considered.  
However, where missing fields were identified, the subjects were removed from the study 
since the variables that were missing or incorrect were essential to the research. To 
include subjects without the information would impact the results in a way inconsistent 
with the research design. In addition, the sample size was large enough and the number of 
cases removed was small enough to maintain statistical power relative to the overall 
number of subjects. Based on these criteria, an additional 96 subjects were removed, 
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leaving a total sample size of 324, as seen in Table 10.  This is the number of subjects for 
the first part of the analysis and used to answer the first research questions: Is there a 
difference in adherence behaviors of individuals in a health plan that implemented a 
system level program and those in a health plan that implemented an individual level 
program only?   
Table 10. Sample Size 
APPROAC
H 
COVERE
D LIVES 
TOTAL 
W/ 
DIABETE
S 
INITIAL 
EXCLUSIO
N  
ADDITIONA
L 
EXCLUSION 
TOTA
L IN 
STUDY 
% OF 
DIABETICS 
IN STUDY 
A - 
Individual 3998 468 278 40 150 32% 
B - System 5046 483 253 56 174 36% 
TOTAL 9044 951 531 96 324 34% 
 
Characteristics of the Study Sample 
Table 11 displays demographic and clinical characteristics of the independent 
variables being studied.  The study sample includes 194 women and 130 men.  The mean 
age of the study sample is 52.1 years with the range being 20 to 64 years old. The average 
number of hospitalizations per subject since start of the diabetes programs is 0.43, with 
the range being zero to six. The subjects have an average of 2.35 co-morbid chronic 
conditions and a range of zero to six conditions. The number of physicians treating each 
subject for diabetes average 3.34 with the range at one to nine.   
Characteristics of Subjects by Approach to Chronic Care Management 
Both health plans whose participants are the subject of this study provided 
different approaches to the management of their covered individuals with diabetes. 
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Table 11. Individual Characteristics of Total Sample 
Characteristic Value Range 
Gender   
Female 194  
 60%  
Male 130  
 40%  
   
Age (Average) 52.1 20-64 
   
Hospitalizations since start of program (Average) 0.43 0-6 
   
Co-morbid Conditions (Average) 2.35 0-6 
   
Physicians treating diabetes (Average) 3.34 1-9 
 
Framed in social ecology theory, one plan implemented a program from a micro-level 
approach while the other plan implemented a micro-, meso, and exo-level approach, 
incorporating support throughout the organization.  The descriptive information on the 
independent variables by approach is presented in Table 12.   
There is no statistically significant difference between the two groups on age, the 
number of physicians treating the subjects for diabetes, and gender.  A statistically 
significant difference is noted on the number of hospitalizations since enrollment in the 
diabetes program.  Subjects in the plan that implemented the individual level approach 
had more hospital admissions (mean=0.56) than subjects in the plan that implemented the 
system level approach (mean=0.31).  There is also a statistically significant difference 
between the two plans on the number of co-morbid conditions with which subjects were 
diagnosed. Conditions included were heart failure, coronary artery disease, hypertension, 
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Table 12. Characteristics of Sample Population Based on Chronic Care Program in 
Which They Participate 
  MICRO -MESO-EXO-
SYSTEM APPROACH 
(System) 
N=174 
MICRO APPROACH 
ONLY  
(Individual) 
 N=150 
    
  M / % SD Range M / % SD Range 
Mean 
Diff p value 
Age 52.35 9.56 20-64 51.81 8.54 29-64 0.537 .413 
Hospitalizations 
since enrollment in 
program 0.31 0.65 0-3 0.56 1.1 0-6 -0.250 .000 
Co-morbid 
conditions 2.55 1.23 0-6 2.11 0.87 0-4 0.433 .000 
Physicians treating 
diabetes 3.42 2.11 1-9 3.25 1.98 1-8 0.173 .288 
Gender: 
  
  
  
  
  
       Female 
98 
56% 
 
  
96 
64% 
 
  
 
.160 
       Male 
76 
44%     
54 
36%         
 
hyperlipidemia, chronic renal failure, asthma / chronic obstructive pulmonary disease, 
and depression.  On average, subjects in the system level plan had a higher number of co-
morbid conditions (mean=2.55) than subjects in the individual level plan (mean=2.11).    
Adherence Differences by Approach to Chronic Care Management 
One question being addressed by this research is: In relation to individuals with 
diabetes is there a difference in adherence behaviors between individuals in a health plan 
that implemented a system level program and those in a health plan that implemented an 
individual level program only?  Results of the chi-square analyses are presented below. 
Adherence to Cholesterol Monitoring 
Recommendations for the management of diabetes include at least annual 
monitoring of the LDL in order to detect changes early in the disease progression 
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(American Diabetes Association, 2007).  The two health plans being studied in this 
research incorporated goals for improving adherence to cholesterol monitoring.  Is there a 
difference post program implementation between the two plans in relation to LDL 
monitoring adherence? This research was conducted to test the null hypothesis that there 
is no significant difference in adherence to lipid monitoring of individuals in a health plan 
that implemented a micro-, meso-, and exosystem (system) approach to chronic care 
management compared to individuals in a health plan that implemented a microsystem 
approach alone (individual). 
Since there was a significant difference in adherence to LDL monitoring between 
the two plans after implementation of the different approaches, further analysis was 
conducted to determine if there was a significant difference between the two health plans 
prior to implementation of the program. Table 13 presents results of the comparison 
between the two health plans on LDL monitoring adherence prior to the start of the 
program.   
Table 13. LDL Adherence Results by Approach - Before 
Adherence 
Result 
  TOTAL MICRO -MESO-EXO-
SYSTEM APPROACH 
(system) 
MICRO 
APPROACH 
ONLY 
(Individual) 
Yes N 107 80 27 
 % 33.0% 46.0% 18.0% 
No N 217 94 123 
  % 67.0% 54.00% 82.0% 
*p=.000 
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The results in Table 13 indicate that prior to implementation of the program there 
was a statistically significant difference in adherence between the two groups with the 
micro-meso-exo system level approach showing a higher percentage of subjects who 
were adherent. The subjects in the micro-, meso- and exo-system level plan had a 46% 
adherence level as compared to the 18% adherence level associated with the micro level 
only approach. 
Table 14 presents the results after the program was implemented.  The results in 
Table 14 indicate a statistically significant difference in adherence to LDL monitoring 
between the two plans after implementation of the different approaches. The system level 
approach is associated with 70.1% adherence to LDL monitoring compared to a 37.3 % 
adherence associated with the individual level approach.  
Table 14. LDL Adherence Results by Approach - After  
 Adherence 
Result 
  TOTAL MICRO -MESO-EXO-
SYSTEM APPROACH 
(system) 
MICRO 
APPROACH 
ONLY 
(Individual) 
Yes N 178 122 56 
 % 54.9% 70.1% 37.3% 
No N 146 52 94 
  % 45.1% 29.90% 62.7% 
*p=.000 
    To determine whether there was a significant difference in adherence before and 
after program implementation, chi square analyses were conducted by each approach on 
the level of adherence before as compared to the level of adherence after.  Table 15 
presents the results of these analyses. For both approaches there was a statistically  
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Table 15. Differences in LDL Adherence from Prior to Post Program by Approach 
  Adherence 
Prior to 
  TOTAL Adherence Post 
No 
Adherence Post 
Yes 
Adherence to LDL 
Guidelines - Micro 
Level Approach 
(Individual) 
No N 123 89 34 
 %  72.4% 27.6% 
Yes N 27 5 22 
 %  18.5% 81.5% 
  
*p=.000 
 X2= 27.431         
Adherence to LDL 
Guidelines - Micro-
Meso-Exo System 
Level Approach 
(System) 
No N 94 45 49 
 %  47.9% 52.1% 
Yes N 80 7 73 
  %   8.8% 91.3% 
 
*p=.000 
 X2= 31.568 
    significant difference in adherence before program implementation as compared to 
adherence after program implementation. For the micro level approach, of the 123 
subjects who were non-adherent prior to program implementation, 72.4% remained non-
adherent after program implementation and 27.6% moved from non-adherence to 
adherence. Of the 27 subjects who were adherent prior, 81.5% remained adherent and 
18.5% moved from adherent into non-adherent. For the micro-meso-exo system approach, 
of the 94 subjects who were non-adherent prior to the implementation of the program, 
more than half moved from non-adherence to adherence (52.1%) and 47.9% remained 
non-adherent.  Of the subjects who were adherent prior, 8.8% moved into non-adherence 
while 91.3% remained adherent. 
Adherence to Retinopathy Monitoring 
Each of the two health plans have integrated retinopathy screening adherence into 
their programs for the management of participants with diabetes. Annual retinopathy 
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screening is the recommended frequency, according to the American Diabetes 
Association (American Diabetes Association, 2007). This research asks the question:  Is 
there a difference in post program implementation between the two plans in relation to 
adherence to retinopathy screening? The hypothesis associated with this question is: there 
is no significant difference in adherence to retinopathy screening of individuals in a 
health plan that implemented a micro-, meso-, and exo-level (system) approach to chronic 
care management compared to individuals in a health plan that implemented a micro-
level (individual) approach alone. Based on what was learned in the analysis of LDL 
adherence analyses of before adherence for the two health plans was conducted as well as 
analyses for post program implementation adherence.  There was no statistically 
significant difference in adherence to retinopathy screening for the two plans prior to 
program implementation (p=.379).  Adherence levels for the micro-, meso-, and exo-level 
approach was 13.8% and for the micro level only was 17.3%.   
There was, however, a statistically significant difference between the two plans in 
retinopathy screening adherence after program implementation (p=.022).  Results for 
adherence levels after program implementation are presented in Table 16.  Although 
adherence is low for both plans, as with LDL adherence, the plan that implemented the 
micro-, meso-, and exosystem approach showed a higher level of compliance (30.5%) 
than the plan that implemented the micro level approach only (19.3%).  
There were statistically significant differences in adherence before program 
implementation and after implementation for the two plans. For the subjects in the plan 
that implemented the micro level only approach, 124 were non- adherent prior to program  
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Table 16. Retinopathy Screening Adherence by Approach - After   
Adherence 
Result 
  TOTAL MICRO -MESO-EXO-
SYSTEM APPROACH 
(system) 
MICRO 
APPROACH 
ONLY 
(Individual) 
Yes N 82 53 29 
 % 25.3% 30.5% 19.3% 
No N 242 121 121 
  % 74.7% 69.50% 80.7% 
*p=.022 
     
implementation. Of these, 95.2% remained non-adherent and 4.8% moved from non-
adherence into adherence. Of the 26 subjects that were adherent prior to program 
implementation, 88.5% remained adherent after program implementation.  For the 
subjects in the plan that implemented the micro, meso and exo system level approach to 
chronic care management, 150 subjects were non-adherent prior to program 
implementation.  Of these, 76% remained non-adherent and 24% moved from adherence 
to non-adherence. Of the 24 subjects who were adherent prior to program 
implementation, 70.8% remained adherent while 29.2% moved from adherence to non-
adherence. One cell, representing the number of participants receiving the micro-level 
only approach who moved from adherence to non-adherence, had less than five 
participants in the cell. Small cell sizes can lead to accepting the null hypothesis when it 
is false. These results are presented in Table 17.   
Adherence to A1c Monitoring 
 Hemoglobin A1c monitoring is recommended at least every six months for 
individuals with diabetes (American Diabetes Association, 2007).  Both health plans 
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Table 17.   Differences in Retinopathy Screening Adherence from Prior to Post Program 
  Adherence 
Prior to 
  TOTAL Adherence Post 
No 
Adherence 
Post 
Yes 
Adherence to 
Retinopathy 
Guidelines - 
Micro Level 
Approach 
(Individual) 
No N 124 118 6 
 %  95.2% 4.8% 
Yes N 26 3 23 
  %   11.5% 88.5% 
  
*p=.000 
X2=96.372         
Adherence to 
Retinopathy 
Guidelines - 
Micro-Meso-Exo 
System Level 
Approach 
(System) 
No N 150 114 36 
 %  76.0% 24.0% 
Yes N 24 7 17 
  %   29.2% 70.8% 
 
*p=.000 
X2=21.424 
     
adopted this frequency goal into their programs and helped to support their participants to 
improve their adherence levels in relation to monitoring A1c.  This research is designed 
to answer whether there is a difference in this monitoring post program implementation 
between the two plans. The following hypothesis was tested: there is no significant 
difference in adherence to hemoglobin A1c monitoring of individuals in a health plan that 
implemented a micro-, meso-, and exosystem approach to chronic care management 
compared to individuals in a health plan that implemented a microsystem approach alone. 
 Table 18 presents the results of the chi square analysis comparing adherence prior 
to program implementation by each approach.   There was a statistically significant 
difference in adherence between the two plans prior to implementing their diabetes  
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Table 18. A1c Adherence Results by Approach - Before 
Adherence 
Result 
  TOTAL MICRO -MESO-EXO-
SYSTEM APPROACH 
(system) 
MICRO 
APPROACH 
ONLY 
(Individual) 
Yes N 70 47 23 
 % 21.6% 27.0% 15.3% 
No N 254 127 127 
  % 78.4% 73.0% 84.7% 
*p=.011 
     
program (p=.011).  Not only did the plan that implemented the system-level approach 
have a higher level of adherence post program implementation than the plan with the 
individual level approach, it also had a higher level of adherence prior to program 
implementation (27.0%) than the plan with the individual-level approach (15.3%). 
As with LDL and retinopathy monitoring, there is a statistically significant 
difference between the two plans in relation to adherence to A1c monitoring during the 
two and a half years after program implementation (p=.000).  There was a 60.3% 
adherent rate for the plan that implemented the system-level approach, as compared to 
16.6% adherence for the plan that implemented the individual-level approach. Based on 
these results the null hypothesis for hemoglobin A1c monitoring adherence is rejected.   
Results are presented in Table 19. 
Comparison by approach to chronic care management shows a statistically 
significant difference in both plans from before program implementation to after program 
implementation.  For the plan that implemented the micro-level approach only, there 
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Table 19. A1c Adherence Results by Approach – After 
Adherence 
Result 
  TOTAL MICRO -MESO-EXO-
SYSTEM APPROACH 
(system) 
MICRO 
APPROACH 
ONLY 
(Individual) 
Yes N 130 105 25 
 % 40.1% 60.3% 16.7% 
No N 194 69 125 
  % 59.9% 39.7% 83.3% 
*p=.000 
     
were 127 subjects who were non-adherent to A1c monitoring.  Of the 127, 90.6% 
remained non-adherent and only 9.4% became adherent. Of the 23 subjects who were 
adherent, 56.5% remained adherent but 43.5% became non-adherent.  Of the 127 non- 
adherent subjects receiving the systems-level approach, 52.0% remained non-adherent 
and 48.0% moved from non-adherence to adherence.  Of the 47 subjects that were 
adherent, 93.6% remained adherent and 6.4% became non-adherent.  The 6.4% represents 
only three subjects in that cell, a problem that can lead to accepting the null hypothesis 
when it is false.  Table 20 summarizes these results. 
Adherence to Nephropathy Monitoring 
 Nephropathy screening is recommended on an annual basis to detect changes in 
kidney function that can be caused by poorly managed diabetes (American Diabetes 
Association, 2007). Both plans made adherence to nephropathy screening one of their 
program goals.  This research is designed to answer the question:  Is there a difference 
post program implementation between the two plans in relation to nephropathy screening 
adherence? The hypothesis being tested is: there is no significant difference in adherence  
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Table 20.   Differences in A1c Screening Adherence from Prior to Post Program 
  Adherence 
Prior to 
  TOTAL Adherence Post 
No 
Adherence 
Post 
Yes 
Adherence to A1c 
Guidelines - 
Micro Level 
Approach 
(Individual) 
No N 127 115 12 
 %  90.6% 9.4% 
Yes N 23 10 13 
  %   43.5% 56.5% 
  
*p=.000 
X2=31.068*         
Adherence to A1c 
Guidelines - 
Micro-Meso-Exo 
System Level 
Approach 
(System) 
No N 127 66 61 
 %  52.0% 48.0% 
Yes N 47 3 44 
  %   6.4% 93.6% 
 
*p=.000 
X2=29.790 
     
to nephropathy screening monitoring of individuals in a health plan that implemented a 
micro-, meso-, and exosystem approach to chronic care management compared to 
individuals in a health plan that implemented a microsystem approach alone. The results 
of the comparison between the two plans on nephropathy screening adherence prior to  
program implementation are presented in Table 21 and show a statistically significant 
difference (p=.001) in adherence prior to program implementation.  There is a high rate 
of non-adherence for both groups with the micro-level only at a 98% non-adherence rate 
and the micro-, meso-, and exo-level approach with an 88.5% non-adherence rate. While 
there are few subjects in one cell, SPSS results indicate that no cells have an expected 
frequency of less than five.  
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Table 21. Nephropathy Screening Adherence Results by Approach - Before 
Adherence 
Result 
  TOTAL MICRO -MESO-EXO-
SYSTEM APPROACH 
(system) 
MICRO 
APPROACH ONLY 
(Individual) 
Yes N 23 20 3 
 % 7.1% 11.5% 2.0% 
No N 301 154 147 
  % 92.9% 88.5% 98.0% 
*p=.001 
     
Results for the analyses on nephropathy screening after program implementation 
are presented in Table 22. The adherence rates are still low. Results show that the plan 
with the micro-level only approach demonstrates a 93.3% non-adherence and the one 
with the micro-, meso- and exo-level approach demonstrates a 64.4% non-adherence rate.   
 In comparing the before program adherence rate to the after program adherence 
rate by the two different approaches there is a statistically significant difference in rates 
of adherence for the micro-, meso-, and exo-level approach (p=.000) and a non- 
significant difference for the micro-level approach (p=.061).  For the system-level  
Table 22. Nephropathy Screening Adherence Results by Approach – After 
Adherence 
Result 
  TOTAL MICRO -MESO-EXO-
SYSTEM APPROACH 
(system) 
MICRO 
APPROACH 
ONLY 
(Individual) 
Yes N 72 62 10 
 % 22.2% 35.6% 6.7% 
No N 252 112 140 
  % 77.8% 64.4% 93.3% 
*p=.000 
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approach, of the 154 non-adherent subjects 29.2% moved from non-adherence to 
adherence and of the 20 subjects that were adherent 85% remained adherent. There are 
four cells, representing movement from non-adherence to adherence for the micro-level 
approach, that have less than five subjects. Table 23 summarizes these results. 
Multivariate Analysis 
Knowing that there is a statistically significant difference between the two 
approaches in adherence results after the programs were implemented is not enough to 
gain an understanding of what contributes to the difference. This is especially important 
when there are still many enrollees who are non-adherent even after implementation of 
the chronic care program. A logistic regression analysis is done to help identify the 
factors that contribute to changes in adherence. Variables of interest in the regression 
analysis are variables that are possible factors that impact adherence behaviors.  Factors 
that are included in the analysis are: age; gender; number of co-morbid conditions; 
number of hospitalizations; number of physicians treating diabetes; and, approach to 
chronic care management.  All factors were entered into the regression analysis to 
determine the predictive relationship to the dependent variable.  
The dependent variables are change in adherence to each of the four 
recommended screenings. Adherence is categorized into no change in adherence or 
positive change in adherence over the two and a half years prior to each program being 
implemented as compared to adherence two and a half years after program 
implementation.  Change in adherence is calculated by taking the number of tests 
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\Table 23.   Differences in Nephropathy Screening Adherence from Prior to Post Program 
  Adherence 
Prior to 
  TOTAL Adherence Post 
No 
Adherence Post 
Yes 
Adherence to 
Nephropathy 
Guidelines - 
Micro Level 
Approach 
(Individual) 
No N 147 138 9 
 %  93.9% 6.1% 
Yes N 3 2 1 
  %   66.7% 33.3% 
  
*ns 
(p=.061)         
Adherence to 
Nephropathy 
Guidelines - 
Micro-Meso-Exo 
System Level 
Approach 
(System) 
No N 154 109 45 
 %  70.8% 29.2% 
Yes N 20 3 17 
  %   15.0% 85.0% 
 
*p=.000 
X2=24.012 
     
performed according to the guidelines after the program start and subtracting the number 
of tests performed according to guidelines before program start.  In some cases the 
subjects were adherent both before and after program implementation.  Those cases were 
removed from these analyses resulting in a different sample size for each measurement. 
The logistic regression is performed for each screening to answer the second research 
question: Can adherence to selected evidence-based guidelines be predicted by age, 
gender, co-morbid conditions, number of hospitalizations, evidence of a consistent 
medical provider, and approach to diabetes management (system-level versus individual-
level only)?  The research is designed to address the following hypothesis for each of the 
recommended screenings: Approach to diabetes management is associated with a change 
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in adherence to select diabetes screenings from pre-program implementation to post 
program implementation. 
Regression Results for Adherence to LDL Monitoring 
In relation to LDL monitoring, 115 cases were removed because of consistent 
adherence from before to after the start of the program, leaving a sample size of 209 
subjects in the analysis. Table 24 presents the results of the logistic regression performed.  
The model being studied, with all independent variables entered into the equation at the 
same time, was found to be statistically significant for predicting adherence (p=.000).  
The independent variables account for 22.5% of the change in LDL adherence 
(Nagelkerke R2).  Analysis of the predictors shows that three of the variables were not 
statistically significant predictors of changes in adherence to LDL monitoring.  The three 
were age, number of medical providers treating diabetes and approach to chronic care 
management.  Three of the variables were found to be statistically significant predictors: 
gender, number of hospitalizations and number of co-morbid conditions.  Gender results 
show that males are less likely to have a change in adherence compared to females.  
Males were 2.3 times less likely to have a change in LDL adherence as compared to 
females.  The number of hospitalizations is predictive of a decrease in adherence. For 
every one unit increase in the number of hospitalizations, subjects were 1.79 times less 
likely to have a change in LDL adherence.  The number of chronic conditions is 
associated with an increase in adherence to LDL.  For every one unit increase in the 
number of chronic conditions, subjects were 1.8 times more likely to show a change in 
LDL adherence. 
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Table 24. Logistic Regression Results for Change in LDL Adherence 
Predictor Β p-
value 
Odds 
ratio  
CI 
Upper Lower 
Age (continuous) .018 .272 1.018 .986 1.051 
Gender (dichotomous) -.869 .007 .419 .224 .785 
Number of hospitalizations 
(continuous) 
-.575 .004 .563 .380 .834 
Number of co-morbid conditions 
(continuous) 
.605 .000 1.832 1.311 2.560 
Number of medical provider treating 
diabetes (continuous) 
-.078 .327 .925 .791 1.081 
Approach to chronic care 
management System / Individual 
(dichotomous) 
.463 .136 1.589 .864 2.921 
                    n = 209 p=.000 
R2=.225 
    
 
Regression Results for Adherence to Retinopathy Monitoring 
 Logistic regression was conducted to determine the independent variables that are 
predictive of changes in adherence to the recommended frequency of retinopathy 
monitoring. This analysis was completed for those subjects who demonstrated a change 
from prior to program implementation to post program implementation, excluding those 
subjects that maintained adherence to the recommended frequency throughout the study 
period.  The number of subjects included in this analysis was 284.  Forty subjects were 
excluded.  The logistic model with all the variables entered in at the same time was a 
statistically significant predictor of change in retinopathy screening adherence (p=.000). 
According to the Negelkerke R2, the independent variables account for only 12.8% of the 
change in adherence.  A review of the impact each variable has as a predictor of change 
shows that only the approach to chronic care management is a statistically significant 
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factor (p=.000).  These results are presented in Table 25.  Subjects are in the plan that 
implemented the micro-, meso- and exo-level approach are 3.2 times more likely to have 
a change in adherence.  
Table 25. Logistic Regression Results for Change in Retinopathy Screening Adherence 
Predictor Β p-
value 
Odds 
ratio  
CI 
Upper Lower 
Age (continuous) .000 .981 1.000 .971 1.029 
Gender (dichotomous) .436 .113 1.547 .901 2.656 
Number of hospitalizations 
(continuous) 
.188 .196 1.206 .908 1.603 
Number of co-morbid conditions 
(continuous) 
.154 .217 1.167 .914 1.490 
Number of medical provider treating 
diabetes (continuous) 
.083 .202 1.086 .957 1.233 
Approach to chronic care 
management System / Individual 
(dichotomous) 
1.176 .000 3.242 1.832 5.737 
                    n = 284 p=.000 
R2=.128 
    
 
Regression Results for Adherence to Hemoglobin A1c Monitoring 
 The number of subjects in the analysis was 248, with 78 subjects removed from 
the analysis because of consistent adherence both before and after program 
implementation.  Just as with LDL and retinopathy adherence, the model was statistically 
significant for predicting adherence to A1c monitoring (p=.000). The independent 
variables account for only 17.7% of the change in adherence (Nagelkerke R Square). As 
with retinopathy screening the only factor that is a statistically significant predictor of 
change in adherence is approach to chronic care management.  Table 26 presents these 
results.  Subjects in the micro-, meso-, and exo-level approach are 3.4 times more likely 
to show changes in adherence than those in the micro-level approach only.  
111 
 
Table 26. Logistic Regression Results for Change in Hemoglobin A1c Adherence 
Predictor Β p-
value 
Odds 
ratio  
CI 
Upper Lower 
Age (continuous) .021 .165 1.021 .991 1.052 
Gender (dichotomous) -.370 .192 .691 .396 1.205 
Number of hospitalizations 
(continuous) 
-.170 .275 .843 .621 1.145 
Number of co-morbid conditions 
(continuous) 
.226 .125 1.254 .939 1.674 
Number of medical provider 
treating diabetes (continuous) 
.083 .233 1.087 .948 1.247 
Approach to chronic care 
management System / Individual 
(dichotomous) 
1.232 .000 3.426 1.968 5.965 
               n = 248 p=.000 
R2=.177 
    
 
Regression Results for Adherence to Nephropathy Monitoring 
 Logistic regression analysis for nephropathy monitoring was conducted in the 
same way as the previous analyses.  There were 300 subjects included in this analysis, 
with 24 removed because of adherence with the frequency guidelines prior to and post 
each plan implementing their chronic care program. All independent variables were 
entered into the analysis at the same time and as with the other results the model was  
statistically significant in predicting change in adherence (p=.000). The independent 
variables account for only 10.6% of the change in nephropathy screening frequency. 
Table 27 presents the contribution each variable contributes to the change in adherence.  
As with retinopathy and A1c monitoring, only the approach to chronic care management 
is a predictor of change in adherence.  Those that received the mico-, meso-, exo-system 
level approach were 2.6 times more likely to have a change in adherence.  
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Table 27. Logistic Regression Results for Change in Nephropathy Screening Adherence 
Predictor Β p-
value 
Odds 
ratio  
CI 
Upper Lower 
Age (continuous) -.004 .758 .996 .969 1.023 
Gender (dichotomous) -.044 .864 .957 .581 1.577 
Number of hospitalizations 
(continuous) 
-.248 .137 .781 .563 1.082 
Number of co-morbid conditions 
(continuous) 
.187 .126 1.205 .949 1.530 
Number of medical provider 
treating diabetes (continuous) 
.026 .669 1.027 .910 1.158 
Approach to chronic care 
management System / Individual 
(dichotomous) 
.967 .000 2.629 1.592 4.342 
               n = 300 p=.000 
R2=.106 
    
 
Additional Analyses 
 In order to gain an understanding of predictors of change in adherence this 
research proposed conducting a logistic regression with data from subjects that had a 
complete change in adherence.  These subjects are those who had no evidence of 
adherence before enrollment in the program and complete adherence according to 
guidelines after enrollment in the program.  This analysis could not be completed, 
however, since there were an insufficient number of subjects who met the criteria.  No 
subjects had a complete change across all screenings.  Few subjects had a complete 
change in adherence to the individual screenings.  LDL had only ten subjects with a 
complete change. For retinopathy screenings there were only eight subjects with a 
complete change. Only 11 subjects had a complete change in adherence to hemoglobin 
A1c monitoring and 21 had a complete change in adherence to nephropathy screening.       
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Summary 
 This study is designed to answer two research questions with four hypotheses 
associated with each.  The first set of four hypotheses presents the null hypothesis, stating 
that there is no difference in adherence behavior between subjects in the two health plans, 
each implementing a different approach to chronic care management.  The hypothesis is 
applied to the four screenings that are recommended as a part of appropriate management 
of diabetes.  Chi square analyses were performed.  For each of the screenings, LDL, 
retinopathy, hemoglobin A1c, and nephropathy, there was a statistically significant 
difference between participants in the two plans, thus the null hypothesis is rejected for 
all.  Table 28 presents these hypotheses and the results.   
 In order to examine the factors that contribute to the change in adherence, logistic 
regression analyses were conducted for each of the recommended screenings.  The four 
hypotheses associated with this part of the research stated that the approach to diabetes 
management was associated with a change in adherence.  For three of the four screenings 
the hypothesis was accepted.  Approach to management was associated with changes in 
adherence to retinopathy, hemoglobin A1c and nephropathy screening.  The approach 
was not a statistically significant predictor of change in adherence to LDL screening. 
Results are summarized in Chapter 5.   
For each of the regression models the effect size is moderate. According to Cohen 
(1988), R squared can be interpreted for the behavioral sciences as a small effect size 
when the value is .01; moderate where the value is .09; and large where the value is .25.  
R squared values ranged from .106 (nephropathy screening) to .225 (LDL), which 
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represent a moderate effect size.  A small to moderate effect size is not uncommon in the 
behavioral sciences.  These results indicate that there is only a moderate correlation 
between the model and changes in adherence.   
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CHAPTER 5: DISCUSSION AND CONCLUSIONS 
 
This chapter presents an overview of the study and a summary of the research 
findings.  Next a discussion of the findings in relation to the research hypotheses is 
presented. Limitations and implications of the study are next discussed.  Finally, policy 
implications are explored.   
Study Summary 
Chronic illnesses continue to be a challenge in terms of the burden to all 
stakeholders in the health care industry and in relation to the personal burden to 
individuals who suffer from the conditions. The health care industry has struggled over 
the years to identify programs and interventions that help in effective management of 
chronic illnesses.  Despite this struggle there has been an increase in the costs related to 
these conditions and consistently poor evidence of adherence to recommendations for 
effective management of the conditions (McGlynn, Asch, Keesey, Hicks, and 
DeCristofaro, 2003; Partnership for solutions, 2004). Diabetes is of particular concern 
because of the involvement of multiple systems as the disease progresses.  The health 
care cost related to these co-morbid conditions is significant (Gerberding, 2005).  
The primary goal of effective chronic care management is to maintain the health 
of the individuals affected by the conditions and as a consequence decrease the costs to 
the stakeholders responsible for the payment of care.  One step to help prevent the 
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progression of disease and the occurrence of co-morbidities is to increase the vigilance in 
relation to early identification of signs of disease progression. Recommended screenings 
for diabetes relate to the major body systems affected by the disease.  Hemoglobin A1c is 
an overall indicator of how well blood sugar is maintained in an acceptable range over 
time.  Low density lipid (LDL) monitoring helps identify cardiac involvement.  
Nephropathy screening is performed for early identification of kidney failure and 
retinopathy screening is performed to identify risk for blindness.  Improving adherence to 
select screenings is a goal of effective management of the condition. 
Historically, one of the major approaches to the management of chronic 
conditions and particularly of diabetes has been disease management.  This initiative has 
focused primarily on individual level approaches to improving management of the 
disease with the primary avenue of intervention educating the individual on self-
management skills.  Disease management has been adopted throughout the health care 
industry by payers and employers who are interested in maintaining costs and improving 
employee’s health and work productivity. Despite adoption of this approach, the control 
of diabetes is still not adequate; control and management of diabetes is still not adequate; 
and, costs continue to increase. Explorations have begun into other approaches to 
improve diabetes management. Programs adopting a systems-level approach have been 
developed but are not widely implemented and studied.  
 The focus of this study is to explore the impact of two different approaches on 
adherence to the recommended screenings for diabetes. The approaches studied were 
implemented by two health plans, one implementing an individual-level approach and the 
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other a system-level approach.  The theoretical framework for this study looks at the 
multilevel influences on an individual’s behavior and posits that multiple factors at 
different levels influence health behaviors.  This framework extends beyond the 
individual influences that are the focus of disease management and includes other 
influences that may impact and individual’s health-related behaviors. 
Overview of the Problem 
According to the most recent National Institute of Health figures 7.8% of 
Americans have diabetes and 24% are undiagnosed (National Institute of Diabetes and 
Digestive and Kidney Diseases, 2008).  Medical costs alone for a person with diabetes 
are three times higher than for those without diabetes (Diabetes Cost Calculator, 2007). 
These costs do not consider the personal costs in terms of lost wages from absences from 
work and the cost to employers for absences and decrease productivity. The stakeholders 
impacted by these costs are the patients who suffer from the illnesses; the employers who 
are responsible for health care costs for the majority of Americans (Ha, 2004); and the 
federal and state governments who carry the burden for costs through Medicaid and 
Medicare.  
In addition to the costs of diabetes the clinical burden of the disease is significant, 
impacting multiple body systems.  This impact is the reason monitoring and educating 
regarding adherence to recommended screening and effective chronic care are key 
components of diabetes management. Maintaining blood sugar within an acceptable 
range is essential to prevent the development of complications and involvement of other 
body systems (Blonde, 2007; Diabetes Control and Complications Trial Research Group,  
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1993).  Individuals with diabetes have double the risk of heart disease and stroke 
(National Institute of Diabetes and Digestive and Kidney Diseases, 2005).  Lowering the 
LDL can reduce the risk of heart attack by 42% (American Heart Association, 2007). 
Monitoring LDL is a significant part of diabetes management and is recommended at 
least annually. Diabetic retinopathy causes 12,000 to 24,000 new cases of blindness every 
year (National Institute of Diabetes and Digestive and Kidney Diseases, 2008). Annual 
eye exams are recommended for patients with diabetes in order to identify early signs of 
retinopathy. Kidney disease leads to significantly higher costs of care and a significant 
burden on the patient who can end up with kidney failure and subsequently be placed on 
dialysis.  Monitoring for nephropathy is essential for early detection and is recommended 
at least annually. Improving adherence to the recommended frequency of these 
screenings is an integral part of most diabetes management programs. 
In regard to the approaches taken by most chronic care management programs, 
the literature review identified few results that had a theoretical foundation.  An analysis 
of the literature resulted in the conclusion that most programs focused on theories that 
were based on individual level influences.  These are theories such as the Health Belief 
Model, the Theory of Planned Behavior and the Transtheoretical Theory of change. 
These theories posit that as an individual becomes increasingly aware of the impact of the 
disease they are more likely to engage in change.  The perception of risk and their sense 
of control and ability to change impact the end result. Self-management education, the 
main focus of most chronic care management programs, is designed to increase the 
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patient’s perception of risk and to help increase their sense of control over being able to 
change.  
 The limitations of individual-level approaches have lead to explorations into 
system-level approaches.  The main systems-level approach that was presented in the 
literature is the Chronic Care Model (CCM) proposed by Wagner, Austin, & Vonkorff, 
(1996). This approach includes self-management support but points to the support that is 
needed within the health system for chronic care.  The concepts in the CCM correspond 
to the components of Social Ecology Theory. Social Ecology Theory posits that an 
individual’s health behaviors are impacted by different spheres of influence. The spheres 
include the individual’s internal factors surrounded by the systems and individuals with 
which they directly interact (microsystem); then surrounded by settings that impact the 
individual but with which they do not interact (meso- and exo-system).  The spheres 
extend to organizations, policies and cultures that impact the adoption of healthy 
behaviors (macro-system). This is the theoretical framework of this study. 
Discussion of the Study 
This research is a retrospective, descriptive non-experimental study using claims 
and enrollment data to identify factors that influence adherence to the selected screenings 
for diabetes management. The subjects were members of two hospital plans, each 
adopting a different approach to diabetes management. One adopted an individual-level 
approach providing self-management education and support (micro-system only).  The 
other adopted a system-level approach, providing support across the organization for 
chronic care management. The components of this approach were consistent with the 
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components of the Chronic Care Model and the micro-, meso and exo-system levels of 
Social Ecology Theory. One of the goals of each of the programs was to improve 
adherence to the recommended screenings. Because of the importance of the screenings 
the dependent variables of this study are adherence to the recommended screening 
frequencies.  
A review of the literature led to the incorporation of select variables as 
independent variables. Age and gender have been linked to adherence to diabetes 
guidelines with results being variable.  There was no literature associating gender with 
adherence to the screenings that are the focus of this study. However, on other measures 
of adherence in diabetes management, where there was a correlation between gender and 
adherence females were less likely to adhere (Hertz, Unger, & Lustik, 2005; Korbel, 
Wiebe, Berg, & Palmer, 2007; McCullum, Hansen, Lu, & Sullivan, 2005). There was no 
literature on the association between age and the dependent variables in this study. 
However, as with gender, there were associations between age and adherence to other 
diabetes guidelines, with varying results.  Two studies report opposite results as far as the 
association between age and adherence (Hartz, et al., 2006; Hertz, Unger, & Lustik). The 
relationship between the patient and their physician and the corresponding association to 
adherence has been reported in the literature (Ciechanowski, et al., 2004; Maddigan, 
Majumdar & Johnson, 2005). Both studies indicate that a consistent and positive patient-
physician relationship may be a significant variable associated with adherence behaviors. 
This study includes an independent variable of the number of physicians involved in the 
management of diabetes.  The assumption is that the more physicians treating diabetes, 
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the less likely the relationship between patient and physician is consistent and productive. 
Two other independent variables were included in the study because they are likely 
associated with an individual’s perception of their risk.  These variables are the presence 
of co-morbid chronic conditions and admissions to the hospital during the post program 
implementation period. They were included in the study with the assumption that 
individuals who are suffering from other conditions and presenting with other 
complications may have a higher sense of risk associated with their disease, thus leading 
to a higher vigilance in relation to managing their disease. The primary independent 
variable of interest is the approach to chronic care management: micro-system only and 
micro-, meso- and exo-system approach.  
The purpose of this research was to explore the impact of the approach to chronic 
care management on adherence.  The questions addressed by the study were whether 
there was a difference in adherence between individuals based on the approach and what 
factors were predictive of changes in adherence from prior to program implementation to 
post program implementation. The statistical analysis was conducted in three phases.  
The first involved descriptive analyses of the population as a whole and then a 
comparison of the two health plans in relation to the descriptive statistics. Chi-square and 
t-tests were conducted on the independent variables. The second phase explored whether 
there were differences between the two health plans on adherence post program 
implementation.  Chi-square analyses were conducted on adherence versus non-
adherence for categorical variables. The third phase involved exploring which of the 
independent variables were associated with a change in adherence from pre-program 
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implementation to post-program implementation. Logistic regression analyses were 
conducted to determine the predictive value of the model and to identify those variables 
predictive of a change over time.      
Major Findings and Implications 
Descriptive Differences between Participants in the Two Health Plans 
The independent variables for the subjects in the two health plans were compared. 
There were no statistically significant differences between subjects in the two health 
plans on the independent variables of age, gender and the number of treating physicians.  
There were statistically significant differences between the two health plans on the 
number of hospitalizations since participants were enrolled in the diabetes programs and 
the number of co-morbid conditions.  Subjects in the individual-level health plan had a 
greater number of hospitalizations (mean = 0.56; range of 0-6) than those in the system-
level health plan (mean = 0.31; range of 0-3). However, subjects in the system-level 
health plan had a greater number of co-morbid conditions (mean = 2.55; range of 0-6) 
than those in the individual-level health plan (mean = 2.11; range of 0-4). While they are 
contradictory as indicators of risk for the two health plans, these two variables were 
included in the analysis as representations of the risk of individuals. According to 
individual level theories, as an individual’s perception of risk increases they are often 
more likely to change health-related behaviors.  Hospital admissions and the presence of 
other co-morbid conditions are seen as factors that raise an individual’s sense of risk. 
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Adherence Differences between Health Plans 
The hypotheses and results are listed in Table 28. In relation to the first research 
question, is there a difference in adherence behaviors of individuals in a health plan that 
implemented a system level program and those in a health plan that took an individual 
level approach to chronic care management, this study first examined the differences in 
adherence among participants before implementation of the programs.  For LDL, A1c 
and nephropathy screenings participants in the two health plans showed a statistically 
significant difference in adherence before implementation with the system-level approach 
consistently demonstrating a higher level of adherence. For retinopathy screening, 
however, there was no statistically significant difference in the level of participant 
adherence between the two health plans before program implementation.  
In relation to the comparison between participant level of adherence in plans with 
differing approaches after program implementation, the major finding was that for all 
four screenings there were statistically significant differences between participants in the 
two different health plans.  After program implementation, the health plan with the 
system-level approach demonstrated a higher level of participant adherence in LDL, 
retinopathy, A1c, and nephropathy screening.  The null hypothesis that there would be no 
difference was therefore rejected for all four of the hypotheses associated with the first 
phase of the study looking only at levels of adherence after implementation.  
Although the null hypotheses were rejected, it was felt that further investigation 
into comparisons between the two approaches before and after program implementation 
was needed. These analyses show that there is a statistically significant difference 
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Table 28. Hypotheses and Corresponding Results. 
HYPOTHESIS RESULTS 
H1. There is no difference in adherence to lipid monitoring of 
individuals in a health plan that implemented a micro-, meso-, and 
exosystem approach to chronic care management compared to 
individuals in a health plan that implemented a microsystem approach 
alone. 
Rejected 
H2. There is no difference in adherence to retinopathy monitoring of 
individuals in a health plan that implemented a micro-, meso-, and 
exosystem approach to chronic care management compared to 
individuals in a health plan that implemented a microsystem approach 
alone. 
Rejected 
H3:  There is no difference in adherence to HbA1c monitoring of 
individuals in a health plan that implemented a micro-, meso-, and 
exosystem approach to chronic care management compared to 
individuals in a health plan that implemented a microsystem approach 
alone. 
Rejected 
H4. There is no difference in adherence to nephropathy monitoring of 
individuals in a health plan that implemented a micro-, meso-, and 
exosystem approach to chronic care management compared to 
individuals in a health plan that implemented a microsystem approach 
alone. 
Rejected 
H5: Approach to diabetes management is associated with a change in 
lipid monitoring adherence from pre-program implementation to post 
program implementation. 
Rejected 
H6: Approach to diabetes management is associated with a change in 
retinopathy monitoring adherence from pre-program implementation to 
post program implementation. 
Accepted 
H7: Approach to diabetes management is associated with a change in 
HbA1c adherence from pre-program implementation to post program 
implementation. 
Accepted 
H8: Approach to diabetes management is associated with a change in 
nephropathy monitoring adherence from pre-program implementation to 
post program implementation. 
Accepted 
 
between adherence before and adherence after for both plans for all dependent variables 
except nephropathy screening. For the health plan that implemented the individual level 
approach there was no statistically significant difference in adherence after as compared 
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to before. In this case the null hypothesis that there is no difference between the before 
and after adherence for nephropathy screening would be accepted.  However, since two 
cells in the output had expected counts less than five, there is a risk in this part of the 
analysis of accepting the null hypothesis when it is false (type 2 error).   
In all cases where there is a significant difference between before program 
implementation adherence and after implementation adherence (LDL, retinopathy, A1c 
screening for both plans) there was a greater percent of participants who moved from 
non-adherence to adherence for the health plan that had adopted the micro-, meso, and 
exo-level approach than the plan that adopted the micro-approach only. In each of the 
before and after comparisons the number of subjects in each cell ranged from one to 154.  
Due to the small number of subjects in the cells it is difficult to draw conclusions on the 
significance of these results.     
The literature provides no information on studies that compare adherence to these 
diabetes guidelines based on the approach to management.  The only studies found in the 
literature regarding a systems level approach were those that implemented only some of 
the components of the Chronic Care Model (Bodenheimer, Wagner, & Grumbach, 2006; 
Piatt et al., 2006; Siminerio, Piatt, & Zgibor, 2005) or those that reported on findings over 
time for patients and physician practices (Siminerio, Zgibor & Solano, Jr., 2004; 
Siminerio, et al., 2006).  No studies compared changes in adherence to any diabetes 
guidelines between traditional individual-level approaches and system-level approaches. 
This study expands the available literature by exploring the impact of implementation of 
all components of the CCM on adherence to select diabetes guidelines and comparing 
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changes in adherence for those receiving this approach versus those receiving a 
traditional individual-level approach. 
Predictors of adherence 
The second major finding of the study answers the research question: Can 
adherence to selected evidence-based guidelines be predicted by age, gender, co-morbid 
conditions, number of hospitalizations, evidence of a consistent medical provider, and 
approach to diabetes management (system-level versus individual-level only)?  The 
multivariate model, including age, gender, number of hospitalizations, number of co-
morbid conditions, number of physicians treating diabetes and approach to chronic care 
management is a statistically significant predictor of changes in adherence over time in 
all four areas of adherence studied in this research.   
The independent variable of interest in this study is the approach to chronic care 
management. For three out of the four screenings the approach to management was a 
statistically significant predictor of changes in adherence and was the only independent 
predictor.  Lipid monitoring is the only screening that did not have the same result.  The 
hypothesis that approach to chronic care management is associated with a change in 
adherence to lipid monitoring was rejected. Since lipid monitoring is a significant 
screening associated with other chronic conditions, the approach to management may 
play less of a role than other factors for this screening.  For the other three screenings 
(hemoglobin A1c, retinopathy and nephropathy screenings), participants who were in the 
plan with the systems-level approach were more likely to exhibit a change in adherence 
than participants in the plan with an individual level approach.  The hypotheses that the 
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approach to chronic care management was associated with a change in adherence were 
accepted for each of these analyses.   
Studying a systems-level approach to chronic care grounded in Social Ecology 
Theory and the implications on adherence behaviors is in its infancy.  The approach to 
studying the impact of implementing the CCM has been to either report on results 
associated with implementation of only some of the components (Bodenheimer, Wagner, 
and Grumbach, 2006) or to report on pre and post implementation results (Piatt et al., 
2006; Siminerio, Piatt, & Zgibor, 2005).  The results in these analyses varied with the 
ones reported by Bodenheimer, Wagner, and Grumbach (2006) and the ones conducted 
by Piatt et al. (2006) and Siminerio, Piatt, & Zgibor (2005). Bodenheimer, Wagner, and 
Grumbach reported improvement in at least one adherence or clinical measure based on 
CCM implementation. Piatt et al. and Siminerio, Piatt, & Zgibor reported no statistically 
significant correlation between CCM implementation and adherence behaviors.  Until 
this research there are no studies that compare a systems-level approach to a standard of 
care approach in which individual level interventions only are implemented.  Of 
significance is the fact that most of the research reported in the literature on the CCM 
involves measuring results for those programs that implemented different components of 
the CCM and not all of the CCM.  The two components that are excluded from many of 
the studies are those components that represent full involvement at a system level: 
organizational changes and the integration of community resources (Bodenheimer, 
Wagner, and Grumbach, 2006).  
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This research reports on an approach that incorporates all components of the 
CCM.  The results suggest that there is a statistically significant relationship between 
implementation of a full systems-level program and changes in adherence.  These results 
are consistent with research reported in relation to other health behaviors (Hopkins, 
Husten, Fielding, Rosenquist & Westphal, 2001; Patrick, Intille & Zabinski, 2005).  
Although this research suggests a correlation between implementation of all components 
of the CCM and changes in adherence the correlation coefficients indicate that only a 
small percentage of the change in adherence are explained by the regression models. 
In addition, although there was a statistically significant change in adherence 
levels based on approach to chronic care management, adherence levels for both health 
plans are lower than what is reported in the literature where national adherence levels are 
known. The national adherence level for A1c monitoring is 64.3 to 68.8%  (Centers for 
Disease Control, 2007) while the adherence level for the plan that implemented the 
micro-level only approach was only 16.7% after the diabetes program  and adherence 
levels for the plan that implemented the micro- meso - exo level plan was 60.3%. 
National adherence levels for retinopathy screenings was reportedly 60.6% (Centers for 
Disease Control, 2007). However, adherence levels for the health plan that implemented 
the micro-system approach only was 19.3% after program implementation and for the 
health plan that implemented the micro- meso - exo system approach the adherence level 
after program implementation was 30.5%.  It is unclear why adherence levels were so 
much lower than nationally reported levels. There are no national adherence levels for the 
other two screenings.      
129 
 
In relation to individual predictors, change in adherence to lipid monitoring was 
the only model where different results than the other three screenings studied were found.  
For lipid screening, gender was predictive of change whereby males were less likely to 
have a change in adherence.  This result differs from the literature on gender and its 
association with adherence to other diabetes guidelines.  In relation to medication and 
diet adherence to improve glucose levels, Hertz, Unger, & Lustik, (2005); Korbel, Wiebe, 
Berg, & Palmer, (2007); and McCullum, Hansen, Lu, & Sullivan, (2005) reported that 
females were less likely to demonstrate adherence.  Since monitoring lipid levels and 
consistently adhering to medications and diet are different actions it may not be 
appropriate to draw any conclusions about the discrepancy between this result and what 
is reported in the literature.  Gender was not a significant predictor of adherence for the 
other three screening dependent variables. 
Number of hospitalizations and number of co-morbid conditions are also 
statistically significant predictors of change in adherence to lipid monitoring.  With an 
increase in the number of hospitalizations and the number of conditions there is an 
increased likelihood of change in adherence. These were not however statistically 
significant predictors of adherence for the other three dependent variables.  Unlike the 
three other screenings, monitoring lipid levels is an important component of managing 
other conditions such as coronary artery disease, hypertension, hyperlipidemia, and heart 
failure and individuals with diabetes may also be diagnosed with these conditions. 
Therefore, the association found may be related because participants who received these 
screenings may also have had other conditions that require these screenings. This may be 
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the reason that lipid screenings were associated with more hospitalizations and a greater 
number of co-morbid conditions, but the other screenings were not.  
However, given the tenet of individual level theory that raising an individual’s 
awareness of risk leads to action, it is significant that hospitalizations and the number of 
co-morbid conditions are not predictive of change in adherence behavior in the other 
three recommended screenings.  Central to the Health Belief Model, the Transtheoretical 
Model of Change, the Theory of Planned Behavior, and the Information-Motivation-
Behavioral Skills Model are the concepts of perception of risk and the patient weighing 
the pros and cons of not changing one’s behavior (Ajzen, 2002 ;DiClemente, Crosby, & 
Kegler, 2002 ;Glanz, Lewis, & Rimer, 1997; & Prochaska & DiClemente, 1983). 
Hospitalizations and the presence of complicating co-morbidities are seen as triggers that 
would raise the patient’s awareness of their risk and the impact that poor management of 
the disease can have on their health.  This research suggests, however, that these risks are 
not alone associated with changes in adherence. 
The literature suggests that a strong patient-physician relationship is significantly 
associated with diabetes outcomes such as diet and exercise adherence (Ciechanowski, et 
al., 2004; Maddigan, Majumdar & Johnson, 2005; Rothman & Wagner, 2003).  The 
literature does not address fragmentation that might occur as the numbers of physicians 
involved with the patient rises, but it does address patients’ perceptions of their 
relationship with their physician and their sense that their physician collaborates with 
them.  This research uses a proxy to measure the patient-physician relationship.  This 
proxy is the number of physicians involved in the management of diabetes. Being unable  
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to measure the exact nature of the patient-physician relationship, the number of 
physicians involved in the care was used, since it is assumed that as the number of 
physicians increases it is less likely patients have a strong, consistent relationship with 
one treating provider.  The possibility for fragmentation of care is assumed to be present 
as the number of treating physicians rises.  It is significant that in this research the 
number of medical providers is not predictive of changes in adherence in any of the four 
dependent variables.  A better measure of the patient-physician relationship may have 
been more predictive.   
Suggestions for Future Research 
Social Ecology Theory and the CCM help to inform suggestions for future 
research.  Both frameworks include individual level approaches as a part of a full system 
approach. The micro-level approaches are informed by individual level theories.  In the 
quest to discover what impacts a person’s engagement in healthy behaviors, these 
individual level theories should be further explored by including all components of the 
theories in the development of programs and in the analyses of the impact of these 
programs.  All of the individual level theories point to the importance of the patient’s 
perception of risk. Most of the interventions examined in the literature and used in 
programs based on individual level approaches focus on raising awareness of the disease; 
the risk associated with the disease; the benefits of action; and the risk of inaction.  Since 
this research suggests that triggers (hospital admissions and co-morbid conditions) that 
should contribute to a high perception of risk are not statistically significant predictors of  
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changing one’s behavior, there may be better measures of the components of individual 
level theories that can be researched in relation to a system-level approach.  
A major tenet of the individual level theory presented in Chapter 2, Information-
Motivation-Behavioral Skills Model (IMB), is that behavioral skills are enhanced by 
focusing on the individual’s ability and perceived ability to perform the sequence of 
behaviors required in the management of one’s health (DiClemente, Crosby, and Kegler, 
2002).  Research that has focused on this approach has been primarily limited to HIV and 
AIDS management. The IMB focuses more on the behavioral skills of the patient than the 
other individual level theories do (Fisher, Fisher, Williams, & Malloy, 1994).  Other 
individual level theories focus on educating and motivating patients. Further research on 
impacting the individual’s behavioral skill level and its relationship to levels of adherence 
to chronic care guidelines can add to understanding how to improve patient adherence.  
Components of behavioral skill building can be integrated into system-level approaches 
and studied to determine the impact in relation to system-level interventions.  
Another individual level factor reported in the literature as positively impacting 
health outcomes is patient-physician relationship.  While this research indicates that the 
number of physicians involved in diabetes care is not predictive of positive outcomes, a 
better measure of this relationship would help to inform programs designed to improve 
diabetes outcomes.  Is the number of physicians an appropriate measure of relationship?  
While it measures the lack of a consistent provider, other measures such as the patient’s 
and physician’s perception of relationship might be a better measure of that relationship.  
The World Health Organization (2003) focuses on the significance of the patient-provider 
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relationship and the need to organize health systems to support that relationship.   
Casalino (2005) points to the fact that most physicians lack the time to focus on the needs 
of patients with chronic illnesses.  He indicates that while disease management programs 
generally focus on direct outreach to the patient, excluding the physician from that 
approach, the chronic care model incorporates the physician in the management of the 
patient.  Additional research on the strength of the patient-physician relationship would 
help to inform programs designed to improve diabetes outcomes.  Such research could 
explore adherence to diabetes guidelines in relation to the quality of the patient-physician 
relationship; the features of that relationship; and the support of that relationship by the 
health system.   
No previous published research compares health and behavioral outcomes for 
individuals receiving interventions from the two approaches presented.  Additional 
research that compares other system level approaches to individual level approaches 
would add to the body of knowledge on what may improve adherence to diabetes 
guidelines.  It is significant that all of the published research on CCM implementation 
reports on programs that implemented only some aspects of the CCM.  The components 
that were implemented involve only micro- and meso-system levels and do not extend to 
the exo-system.  This excludes organizational support for chronic care management.  
Additional research on programs that implement all components of the CCM will help 
the health care industry to identify more effective ways to impact diabetes outcomes.   
There are increasing numbers of programs that report implementing all 
components of the CCM.  Such programs include the Mayo Clinic (Smith, et al., 2008) 
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and Intermountain Healthcare (Dorr, et al., 2006).  The federal government, through the 
Health Resource and Services Administration and specifically the Health Disparities 
Coalition, has begun to support initiatives for implementing the Chronic Care Model 
(Health Resources and Services Administration, [ca. 2007]). The initiative supports 
Federally Qualified Health Centers that implement the model.  The coalition indicates 
that the six components of the model interact with each other and must be addressed to 
achieve significant change.  As these health centers implement programs based on the 
model opportunities for further research will be available.  
The macro-level, as reflected in Social Ecology Theory, is the overall context in 
which all levels exist.  The CCM, as it originally was designed, does not include the 
larger community and policy context but rather approaches chronic care management 
from an organization level. However, the World Health Organization and the McColl 
Institute for Healthcare Innovations have joined to expand the CCM to the Innovative 
Care for Chronic Conditions framework.  Policy and wider community interventions are 
integrated into the framework to provide a more comprehensive milieu for chronic care 
management (Epping-Jordan, Pruitt, Bengoa & Wagner, 2004).  The authors indicate that 
a wider support for chronic care management needs to include leadership and advocacy 
for chronic care; policy changes designed to decrease fragmentation and redundancies in 
care; financial commitment for chronic care; and partnerships between private sector, 
government and community organizations. This development will lead to multiple 
opportunities for research.  
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Study Limitations 
There are four major aspects of the study that result in limitations beyond the 
methodological limitations that were discussed in Chapter 3.  The first is related to the 
characteristics of the study population, as well as what is not known, that makes it 
difficult to conclude that these results would be reflected in other populations. The 
subjects involved in this study sample were employees and dependents of two hospital 
systems in Maryland who were enrolled in employer health plans.  While no literature 
found indicates that hospital employees are any more or less likely to adhere to diabetes 
guidelines, the use of hospital employees and their dependents limits the ability to 
conclude that the results might be the same or similar for other populations.  Thus, the 
sample does not reflect the entire population with diabetes. This fact limits the ability to 
conclude that the results could be applied to individuals who are uninsured or insured by 
public programs.   
In addition, no information on socioeconomic status or race was available for 
individuals in this study.  The Center for Health Care Strategies reports that members of 
racial and ethnic minority groups experience poorer quality of care; greater barriers to 
accessing necessary services; and consequently poorer adherence to evidence based care 
for diabetes (Martin, 2007). In the absence of information on socio-economic, racial and 
ethnic characteristics there are no conclusions that can be drawn regarding other barriers 
to accessing appropriate care and ways to impact adherence to recommended guidelines 
that address these barriers. Since all of the subjects in this study were employed or 
dependents of employed individuals and are covered by private insurance there are 
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limitations in the conclusions that can be drawn on how the approach to chronic care 
management would impact the uninsured or those insured under public insurances, such 
as Medicare or Medicaid. The geographical location of the hospital systems also limits 
generalizability.  The hospitals are located in more rural parts of one state. Additional 
research on other groups in other locations would need to be conducted in order to 
strengthen the usefulness of the results.   
The second area that contributes to study limitations is the use of administrative 
data.  Administrative data are obtained for purposes other than research, such as medical 
claims payment. Although the literature indicates that data from claims are acceptable, 
particularly for identifying utilization patterns, there were no means to assess validity and 
reliability of the data.  Assumptions are made that, since the same TPA and claims 
management systems are used for both groups, comparisons between the two on the 
dependent variables (utilization patterns that indicate adherence or non-adherence) have 
comparable levels of accuracy.  For the measurement of the independent variables, the 
data available may be limited representative measures of the variable of interest.  For 
instance, assumptions were made that an increase in numbers of hospitalizations and the 
number of co-morbid conditions raise a person’s awareness of risk.  Other measures of 
awareness of risk may better represent individual perceptions.  Similarly, assumptions 
were made that the number of physicians involved with a patient in the care of diabetes is 
an adequate measure of patient-physician involvement.  Fewer physicians involved in the 
care of individuals with diabetes was seen as a proxy for a more consistent and effective 
relationship. Other measures may more accurately represent this relationship.  Patients’ 
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and physicians’ perception of the relationship, measured by survey results, may be better 
measures of the predictive value in relation to improvement in adherence.       
The third area that may be considered a limitation is the sample size.  The second 
phase of the study, in which comparisons were conducted between the two approaches on 
adherence pre - and post-program implementation, all subjects were included in the 
analysis (324).  This sample size was adequate for the chi-square and t-tests performed in 
this phase.  Initially, the same sample size would be maintained for the logistic regression 
analysis as well. The analysis of adherence change lead to a determination that some of 
the subjects had to be removed since they were adherent throughout the study period.  As 
a result, sample sizes were different for each dependent variable. Sample size met the 300 
subject criteria for nephropathy screening.  For the other three screenings sample size 
ranged from 209 to 284. The lower than initially accepted sample size can lead to an 
over-estimation of the odds ratio and a possible type 2 error (Nemes, Jonasson, Genell, & 
Steineck, 2009).    
The fourth area is related to the effect sizes in the regression analyses.  The results 
indicate the regression models account for only 10.6% to 22.5% of the change in 
adherence, a moderate effect size. These should be considered in relation to resources 
that are expended in implementing and sustaining a system-level approach to chronic care 
management. Additional research with a larger number of subjects and more specific 
measurement of the variables of interest may lead to a larger effect size.  
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Conclusions 
Chronic illnesses and particularly diabetes continue to challenge the health care 
industry to identify ways to improve care. The management of chronic conditions is seen 
as a major challenge for the 21st century.  Since the early 1990s employers and 
governments have supported and implemented disease management programs in the hope 
that these programs would slow chronic illness progression. Employers and governments 
hoped that these programs would have a positive impact on individuals and payers who 
feel the burden in terms of poor health, increased health care costs, and decreased 
productivity. These programs focused exclusively on individual level approaches to 
change behavior. The main focus of these programs was on raising an individual’s 
awareness of the disease, the impact of in-action, and self-management skills.   
Outcomes from an individual approach only to address behavior change have 
been varied.  In an effort to find other, more successful ways to impact chronic illnesses a 
system level approach based on Social Ecology Theory was proposed by Wagner, Austin, 
& Vonkorff (1996).  The Chronic Care Model (CCM) has 6 components which span most 
of the Social Ecology Theory levels.  The CCM integrates the micro-, meso- and exo-
system levels into the model. The components include organizational support for chronic 
care management, acknowledging that most care in the current health system is geared 
towards acute care.  Very little research has been conducted on the impact of the CCM on 
adherence to screenings that are recommended for individuals with diabetes.  Wagner 
(1997; p. 702) called for research on new models of care, stating that “Following the 
failure of health care reform, we are experiencing unprecedented, unevaluated tinkering 
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with basic care models and values”.  The published research did not evaluate the 
difference between the more traditional approach to chronic care management (an 
individual level approach) and a system-level approach such as the CCM.  In addition, 
where there was research on the CCM, it primarily addressed programs that implemented 
only some of the features of the model.  However, as the Health Disparities Coalition 
pointed out, the six components of the model interact with each other and all must be 
addressed to achieve significant change. 
The study supports the conclusion that an approach to diabetes management that 
incorporates all six elements of the CCM has a greater impact on adherence than the 
traditional individual level approach. The research went on to examine the factors that are 
associated with changes in adherence from before program implementation to after 
program implementation.  Along with the type of approach to chronic care management, 
individual level variables were included in an assessment of adherence to screenings.  For 
all but LDL monitoring, the study suggests that a system approach to chronic care 
management was a statistically significant predictor of change in adherence.  
This research is a step in understanding effective diabetes management.  The 
strategies discussed here can be applied to other programs for chronic illness 
management.  With the challenges of chronic illnesses, including obesity, looming ahead 
of us and the struggles to find what motivates a person to change, this research sheds 
some light on ways to impact positive outcomes. Individual-level approaches can be 
enhanced through support and processes that are implemented at a system level and that 
are designed to impact chronic illness care.  
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APPENDIX A 
 
Adherence Guidelines Used by Both Plans 
The following are the adherence guidelines that are excerpted from the medical 
management software used by both plans both plans to educate the participants with 
diabetes on adherence to diabetes guidelines.  
Hemoglobin A1c - 
 
LDL - 
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Nephropathy - 
 
 
Retinopathy - 
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APPENDIX B 
 
Participant Level Claims Information 
The following is a sample of a patient synopsis report that organizes claims to provide 
information on adherence practices in relation to clinical guidelines.  This information is 
used by the nurses providing self-management support.  This was also by the plan that 
implemented the system-level approach to provide feedback to the treating physicians. 
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APPENDIX C 
 
Quality Report Card for Data 
The Report Card Tool checks for all information, summarizes information in 
different ways to spot errors or incomplete data. Below is a sample page for the two plans.  
This report card is run every time a claims or eligibility load is received by the Third 
Party Administrator.  
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